| GO Terms | Score | Description |
|---|---|---|
| GO:0008150 | 83.12% | biological_process |
| GO:0050896 | 65.63% | response to stimulus |
| GO:0065007 | 58.53% | biological regulation |
| GO:0050789 | 57.57% | regulation of biological process |
| GO:0050794 | 56.91% | regulation of cellular process |
| GO:0031323 | 56.27% | regulation of cellular metabolic process |
| GO:0019222 | 55.72% | regulation of metabolic process |
| GO:0060255 | 53.12% | regulation of macromolecule metabolic process |
| GO:0080090 | 47.70% | regulation of primary metabolic process |
| GO:0051171 | 46.25% | regulation of nitrogen compound metabolic process |
| GO:0048519 | 45.80% | negative regulation of biological process |
| GO:0048523 | 45.17% | negative regulation of cellular process |
| GO:0006950 | 42.58% | response to stress |
| GO:0032268 | 42.27% | regulation of cellular protein metabolic process |
| GO:0051246 | 42.15% | regulation of protein metabolic process |
| GO:0009987 | 39.13% | cellular process |
| GO:0048518 | 37.49% | positive regulation of biological process |
| GO:0048522 | 37.48% | positive regulation of cellular process |
| GO:0030162 | 37.32% | regulation of proteolysis |
| GO:0009892 | 37.13% | negative regulation of metabolic process |
| GO:0031324 | 36.41% | negative regulation of cellular metabolic process |
| GO:0045861 | 35.87% | negative regulation of proteolysis |
| GO:0051172 | 35.39% | negative regulation of nitrogen compound metabolic process |
| GO:0010605 | 34.81% | negative regulation of macromolecule metabolic process |
| GO:0051239 | 34.36% | regulation of multicellular organismal process |
| GO:0031325 | 34.18% | positive regulation of cellular metabolic process |
| GO:0009893 | 34.07% | positive regulation of metabolic process |
| GO:0032269 | 33.88% | negative regulation of cellular protein metabolic process |
| GO:0010604 | 33.87% | positive regulation of macromolecule metabolic process |
| GO:0051248 | 33.39% | negative regulation of protein metabolic process |
| GO:0065009 | 31.58% | regulation of molecular function |
| GO:0050793 | 31.11% | regulation of developmental process |
| GO:0006952 | 30.90% | defense response |
| GO:0031329 | 30.44% | regulation of cellular catabolic process |
| GO:0032502 | 30.16% | developmental process |
| GO:0050790 | 30.01% | regulation of catalytic activity |
| GO:0052547 | 29.77% | regulation of peptidase activity |
| GO:0051346 | 29.75% | negative regulation of hydrolase activity |
| GO:0009894 | 29.05% | regulation of catabolic process |
| GO:0048856 | 28.60% | anatomical structure development |
| GO:0008284 | 28.58% | positive regulation of cell population proliferation |
| GO:0051336 | 28.49% | regulation of hydrolase activity |
| GO:0010466 | 28.29% | negative regulation of peptidase activity |
| GO:0043086 | 28.09% | negative regulation of catalytic activity |
| GO:0051128 | 27.96% | regulation of cellular component organization |
| GO:0044092 | 27.44% | negative regulation of molecular function |
| GO:0042127 | 27.03% | regulation of cell population proliferation |
| GO:0031330 | 26.94% | negative regulation of cellular catabolic process |
| GO:0009895 | 26.12% | negative regulation of catabolic process |
| GO:0009889 | 26.11% | regulation of biosynthetic process |
| GO:0045740 | 25.75% | positive regulation of DNA replication |
| GO:0010712 | 25.62% | regulation of collagen metabolic process |
| GO:0022603 | 25.54% | regulation of anatomical structure morphogenesis |
| GO:0006275 | 25.42% | regulation of DNA replication |
| GO:0071840 | 25.39% | cellular component organization or biogenesis |
| GO:0016043 | 25.29% | cellular component organization |
| GO:0010941 | 25.27% | regulation of cell death |
| GO:0031326 | 24.88% | regulation of cellular biosynthetic process |
| GO:0043067 | 24.87% | regulation of programmed cell death |
| GO:0048869 | 24.81% | cellular developmental process |
| GO:0051241 | 24.70% | negative regulation of multicellular organismal process |
| GO:0051093 | 24.69% | negative regulation of developmental process |
| GO:0042176 | 23.95% | regulation of protein catabolic process |
| GO:0009891 | 23.85% | positive regulation of biosynthetic process |
| GO:0009605 | 23.73% | response to external stimulus |
| GO:0010556 | 23.30% | regulation of macromolecule biosynthetic process |
| GO:2000112 | 23.22% | regulation of cellular macromolecule biosynthetic process |
| GO:0051129 | 23.00% | negative regulation of cellular component organization |
| GO:0042221 | 22.85% | response to chemical |
| GO:0060548 | 22.78% | negative regulation of cell death |
| GO:0042177 | 22.70% | negative regulation of protein catabolic process |
| GO:0010033 | 22.40% | response to organic substance |
| GO:0031328 | 22.37% | positive regulation of cellular biosynthetic process |
| GO:0010557 | 21.99% | positive regulation of macromolecule biosynthetic process |
| GO:0097435 | 21.59% | supramolecular fiber organization |
| GO:0006979 | 21.53% | response to oxidative stress |
| GO:1903053 | 21.37% | regulation of extracellular matrix organization |
| GO:0034104 | 20.92% | negative regulation of tissue remodeling |
| GO:0034103 | 20.77% | regulation of tissue remodeling |
| GO:0051716 | 20.67% | cellular response to stimulus |
| GO:1903018 | 19.66% | regulation of glycoprotein metabolic process |
| GO:0009628 | 18.83% | response to abiotic stimulus |
| GO:1901700 | 18.77% | response to oxygen-containing compound |
| GO:0009725 | 18.52% | response to hormone |
| GO:0009719 | 18.44% | response to endogenous stimulus |
| GO:0048513 | 18.43% | animal organ development |
| GO:0022414 | 18.25% | reproductive process |
| GO:0009991 | 18.09% | response to extracellular stimulus |
| GO:0051173 | 18.08% | positive regulation of nitrogen compound metabolic process |
| GO:0009593 | 17.87% | detection of chemical stimulus |
| GO:0033993 | 17.78% | response to lipid |
| GO:0051606 | 17.76% | detection of stimulus |
| GO:0031667 | 17.60% | response to nutrient levels |
| GO:0014070 | 17.59% | response to organic cyclic compound |
| GO:0070887 | 17.58% | cellular response to chemical stimulus |
| GO:0050906 | 17.36% | detection of stimulus involved in sensory perception |
| GO:0001580 | 17.31% | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0070482 | 17.28% | response to oxygen levels |
| GO:0050912 | 17.26% | detection of chemical stimulus involved in sensory perception of taste |
| GO:0050907 | 17.17% | detection of chemical stimulus involved in sensory perception |
| GO:0006955 | 17.10% | immune response |
| GO:0033554 | 17.09% | cellular response to stress |
| GO:0003006 | 17.08% | developmental process involved in reproduction |
| GO:0008219 | 16.66% | cell death |
| GO:0002376 | 16.25% | immune system process |
| GO:0065008 | 16.18% | regulation of biological quality |
| GO:0006915 | 16.02% | apoptotic process |
| GO:0012501 | 15.80% | programmed cell death |
| GO:0036293 | 15.68% | response to decreased oxygen levels |
| GO:0008406 | 15.57% | gonad development |
| GO:0048468 | 15.56% | cell development |
| GO:0001666 | 15.50% | response to hypoxia |
| GO:0032355 | 15.48% | response to estradiol |
| GO:0009636 | 15.44% | response to toxic substance |
| GO:0009611 | 15.36% | response to wounding |
| GO:0007610 | 15.30% | behavior |
| GO:0051240 | 15.28% | positive regulation of multicellular organismal process |
| GO:0042493 | 15.21% | response to drug |
| GO:0010035 | 15.13% | response to inorganic substance |
| GO:0046677 | 14.88% | response to antibiotic |
| GO:0009607 | 14.84% | response to biotic stimulus |
| GO:1901701 | 14.74% | cellular response to oxygen-containing compound |
| GO:0043207 | 14.74% | response to external biotic stimulus |
| GO:0030154 | 14.74% | cell differentiation |
| GO:0008584 | 14.60% | male gonad development |
| GO:0048511 | 14.24% | rhythmic process |
| GO:0009410 | 14.22% | response to xenobiotic stimulus |
| GO:0048732 | 14.15% | gland development |
| GO:0051704 | 14.13% | multi-organism process |
| GO:0001775 | 14.02% | cell activation |
| GO:0000302 | 13.67% | response to reactive oxygen species |
| GO:0048608 | 13.60% | reproductive structure development |
| GO:0007623 | 13.52% | circadian rhythm |
| GO:0042542 | 13.43% | response to hydrogen peroxide |
| GO:0042592 | 13.40% | homeostatic process |
| GO:0034614 | 13.25% | cellular response to reactive oxygen species |
| GO:0051707 | 13.19% | response to other organism |
| GO:0097237 | 12.92% | cellular response to toxic substance |
| GO:0048583 | 12.89% | regulation of response to stimulus |
| GO:0051094 | 12.70% | positive regulation of developmental process |
| GO:0071236 | 12.59% | cellular response to antibiotic |
| GO:0032501 | 12.49% | multicellular organismal process |
| GO:0009743 | 12.46% | response to carbohydrate |
| GO:0035690 | 12.37% | cellular response to drug |
| GO:2000026 | 12.31% | regulation of multicellular organismal development |
| GO:0010468 | 12.19% | regulation of gene expression |
| GO:0070301 | 12.05% | cellular response to hydrogen peroxide |
| GO:0001934 | 12.05% | positive regulation of protein phosphorylation |
| GO:0042325 | 11.98% | regulation of phosphorylation |
| GO:0098542 | 11.96% | defense response to other organism |
| GO:0034599 | 11.92% | cellular response to oxidative stress |
| GO:0007622 | 11.79% | rhythmic behavior |
| GO:0051247 | 11.76% | positive regulation of protein metabolic process |
| GO:0032270 | 11.73% | positive regulation of cellular protein metabolic process |
| GO:0042327 | 11.73% | positive regulation of phosphorylation |
| GO:0009653 | 11.64% | anatomical structure morphogenesis |
| GO:0048512 | 11.62% | circadian behavior |
| GO:0048678 | 11.56% | response to axon injury |
| GO:0001932 | 11.48% | regulation of protein phosphorylation |
| GO:0019220 | 11.40% | regulation of phosphate metabolic process |
| GO:0051174 | 11.40% | regulation of phosphorus metabolic process |
| GO:0009617 | 11.23% | response to bacterium |
| GO:0009888 | 11.17% | tissue development |
| GO:0001894 | 11.11% | tissue homeostasis |
| GO:0007566 | 10.95% | embryo implantation |
| GO:0007423 | 10.82% | sensory organ development |
| GO:0060249 | 10.74% | anatomical structure homeostasis |
| GO:0007165 | 10.64% | signal transduction |
| GO:0045937 | 10.60% | positive regulation of phosphate metabolic process |
| GO:0006959 | 10.59% | humoral immune response |
| GO:0080134 | 10.46% | regulation of response to stress |
| GO:0042742 | 10.40% | defense response to bacterium |
| GO:0010562 | 10.30% | positive regulation of phosphorus metabolic process |
| GO:0048584 | 10.16% | positive regulation of response to stimulus |
| GO:0051962 | 10.15% | positive regulation of nervous system development |
| GO:0002064 | 10.13% | epithelial cell development |
| GO:0050679 | 9.89% | positive regulation of epithelial cell proliferation |
| GO:0019730 | 9.85% | antimicrobial humoral response |
| GO:0001654 | 9.83% | eye development |
| GO:0031401 | 9.83% | positive regulation of protein modification process |
| GO:0007420 | 9.82% | brain development |
| GO:0007154 | 9.80% | cell communication |
| GO:0010628 | 9.53% | positive regulation of gene expression |
| GO:0052548 | 9.49% | regulation of endopeptidase activity |
| GO:0050678 | 9.49% | regulation of epithelial cell proliferation |
| GO:0003008 | 9.44% | system process |
| GO:0050727 | 9.25% | regulation of inflammatory response |
| GO:0061844 | 9.23% | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0006954 | 9.18% | inflammatory response |
| GO:0042981 | 9.13% | regulation of apoptotic process |
| GO:0048585 | 9.09% | negative regulation of response to stimulus |
| GO:0031644 | 9.03% | regulation of nervous system process |
| GO:0007281 | 8.99% | germ cell development |
| GO:0007166 | 8.99% | cell surface receptor signaling pathway |
| GO:0031347 | 8.95% | regulation of defense response |
| GO:0032101 | 8.92% | regulation of response to external stimulus |
| GO:0021700 | 8.88% | developmental maturation |
| GO:1902531 | 8.85% | regulation of intracellular signal transduction |
| GO:0051960 | 8.82% | regulation of nervous system development |
| GO:1901698 | 8.61% | response to nitrogen compound |
| GO:0019219 | 8.60% | regulation of nucleobase-containing compound metabolic process |
| GO:0045595 | 8.57% | regulation of cell differentiation |
| GO:0007286 | 8.56% | spermatid development |
| GO:0050829 | 8.56% | defense response to Gram-negative bacterium |
| GO:0040008 | 8.55% | regulation of growth |
| GO:0045597 | 8.54% | positive regulation of cell differentiation |
| GO:0044057 | 8.53% | regulation of system process |
| GO:0009967 | 8.43% | positive regulation of signal transduction |
| GO:0031399 | 8.39% | regulation of protein modification process |
| GO:0045087 | 8.33% | innate immune response |
| GO:0010243 | 8.30% | response to organonitrogen compound |
| GO:1902533 | 8.27% | positive regulation of intracellular signal transduction |
| GO:0002237 | 8.26% | response to molecule of bacterial origin |
| GO:0008152 | 8.25% | metabolic process |
| GO:0009966 | 8.22% | regulation of signal transduction |
| GO:0051130 | 8.19% | positive regulation of cellular component organization |
| GO:0032102 | 8.09% | negative regulation of response to external stimulus |
| GO:0008283 | 8.07% | cell population proliferation |
| GO:0023056 | 8.01% | positive regulation of signaling |
| GO:0001895 | 7.98% | retina homeostasis |
| GO:0007267 | 7.97% | cell-cell signaling |
| GO:0023052 | 7.97% | signaling |
| GO:0010951 | 7.95% | negative regulation of endopeptidase activity |
| GO:0048469 | 7.92% | cell maturation |
| GO:2000116 | 7.88% | regulation of cysteine-type endopeptidase activity |
| GO:0010647 | 7.87% | positive regulation of cell communication |
| GO:0045935 | 7.80% | positive regulation of nucleobase-containing compound metabolic process |
| GO:0022412 | 7.79% | cellular process involved in reproduction in multicellular organism |
| GO:0034097 | 7.78% | response to cytokine |
| GO:0010720 | 7.76% | positive regulation of cell development |
| GO:0031960 | 7.75% | response to corticosteroid |
| GO:0010629 | 7.71% | negative regulation of gene expression |
| GO:0071310 | 7.66% | cellular response to organic substance |
| GO:0043069 | 7.65% | negative regulation of programmed cell death |
| GO:0048638 | 7.65% | regulation of developmental growth |
| GO:0060284 | 7.58% | regulation of cell development |
| GO:0044093 | 7.55% | positive regulation of molecular function |
| GO:0043066 | 7.48% | negative regulation of apoptotic process |
| GO:0023051 | 7.43% | regulation of signaling |
| GO:0071496 | 7.42% | cellular response to external stimulus |
| GO:0009314 | 7.36% | response to radiation |
| GO:0010646 | 7.36% | regulation of cell communication |
| GO:0010976 | 7.34% | positive regulation of neuron projection development |
| GO:0007218 | 7.33% | neuropeptide signaling pathway |
| GO:0043408 | 7.32% | regulation of MAPK cascade |
| GO:0048232 | 7.32% | male gamete generation |
| GO:0031346 | 7.30% | positive regulation of cell projection organization |
| GO:0070613 | 7.29% | regulation of protein processing |
| GO:0031348 | 7.28% | negative regulation of defense response |
| GO:0007568 | 7.28% | aging |
| GO:0051384 | 7.28% | response to glucocorticoid |
| GO:0002682 | 7.23% | regulation of immune system process |
| GO:0080135 | 7.23% | regulation of cellular response to stress |
| GO:0007283 | 7.13% | spermatogenesis |
| GO:0032496 | 7.11% | response to lipopolysaccharide |
| GO:0050769 | 7.05% | positive regulation of neurogenesis |
| GO:0035821 | 7.04% | modification of morphology or physiology of other organism |
| GO:0022607 | 7.00% | cellular component assembly |
| GO:0001817 | 7.00% | regulation of cytokine production |
| GO:1901360 | 6.96% | organic cyclic compound metabolic process |
| GO:0048609 | 6.96% | multicellular organismal reproductive process |
| GO:0050728 | 6.95% | negative regulation of inflammatory response |
| GO:0044419 | 6.92% | interspecies interaction between organisms |
| GO:0007167 | 6.90% | enzyme linked receptor protein signaling pathway |
| GO:0007276 | 6.88% | gamete generation |
| GO:0044237 | 6.85% | cellular metabolic process |
| GO:0001819 | 6.84% | positive regulation of cytokine production |
| GO:0006928 | 6.76% | movement of cell or subcellular component |
| GO:0002062 | 6.76% | chondrocyte differentiation |
| GO:0009887 | 6.75% | animal organ morphogenesis |
| GO:0043410 | 6.69% | positive regulation of MAPK cascade |
| GO:0043434 | 6.68% | response to peptide hormone |
| GO:1903317 | 6.67% | regulation of protein maturation |
| GO:0002526 | 6.64% | acute inflammatory response |
| GO:1901215 | 6.63% | negative regulation of neuron death |
| GO:0008285 | 6.62% | negative regulation of cell population proliferation |
| GO:0001101 | 6.60% | response to acid chemical |
| GO:1901652 | 6.59% | response to peptide |
| GO:0045786 | 6.58% | negative regulation of cell cycle |
| GO:0048646 | 6.58% | anatomical structure formation involved in morphogenesis |
| GO:0051252 | 6.56% | regulation of RNA metabolic process |
| GO:0009890 | 6.54% | negative regulation of biosynthetic process |
| GO:0006725 | 6.54% | cellular aromatic compound metabolic process |
| GO:0010942 | 6.51% | positive regulation of cell death |
| GO:0062012 | 6.47% | regulation of small molecule metabolic process |
| GO:0050830 | 6.46% | defense response to Gram-positive bacterium |
| GO:0032677 | 6.44% | regulation of interleukin-8 production |
| GO:0007569 | 6.41% | cell aging |
| GO:0043170 | 6.40% | macromolecule metabolic process |
| GO:0045666 | 6.39% | positive regulation of neuron differentiation |
| GO:0048545 | 6.36% | response to steroid hormone |
| GO:0050795 | 6.36% | regulation of behavior |
| GO:0043068 | 6.33% | positive regulation of programmed cell death |
| GO:0031668 | 6.32% | cellular response to extracellular stimulus |
| GO:0002443 | 6.29% | leukocyte mediated immunity |
| GO:0006953 | 6.28% | acute-phase response |
| GO:0051052 | 6.28% | regulation of DNA metabolic process |
| GO:0045930 | 6.25% | negative regulation of mitotic cell cycle |
| GO:0002683 | 6.22% | negative regulation of immune system process |
| GO:0043065 | 6.22% | positive regulation of apoptotic process |
| GO:0009416 | 6.21% | response to light stimulus |
| GO:0006355 | 6.20% | regulation of transcription, DNA-templated |
| GO:0097305 | 6.20% | response to alcohol |
| GO:0002252 | 6.19% | immune effector process |
| GO:2001141 | 6.19% | regulation of RNA biosynthetic process |
| GO:0071704 | 6.19% | organic substance metabolic process |
| GO:0040011 | 6.18% | locomotion |
| GO:0031646 | 6.17% | positive regulation of nervous system process |
| GO:0001906 | 6.16% | cell killing |
| GO:0048146 | 6.16% | positive regulation of fibroblast proliferation |
| GO:0031214 | 6.15% | biomineral tissue development |
| GO:0110148 | 6.11% | biomineralization |
| GO:1903506 | 6.08% | regulation of nucleic acid-templated transcription |
| GO:0010467 | 6.07% | gene expression |
| GO:0045862 | 6.05% | positive regulation of proteolysis |
| GO:0070372 | 6.05% | regulation of ERK1 and ERK2 cascade |
| GO:0070997 | 6.05% | neuron death |
| GO:0050767 | 6.04% | regulation of neurogenesis |
| GO:0070374 | 6.00% | positive regulation of ERK1 and ERK2 cascade |
| GO:0010506 | 5.98% | regulation of autophagy |
| GO:0009266 | 5.95% | response to temperature stimulus |
| GO:0071495 | 5.94% | cellular response to endogenous stimulus |
| GO:0050877 | 5.91% | nervous system process |
| GO:0031327 | 5.90% | negative regulation of cellular biosynthetic process |
| GO:0071453 | 5.87% | cellular response to oxygen levels |
| GO:0006810 | 5.84% | transport |
| GO:0051254 | 5.84% | positive regulation of RNA metabolic process |
| GO:1901214 | 5.84% | regulation of neuron death |
| GO:0019221 | 5.83% | cytokine-mediated signaling pathway |
| GO:0031669 | 5.78% | cellular response to nutrient levels |
| GO:0001909 | 5.78% | leukocyte mediated cytotoxicity |
| GO:2000117 | 5.78% | negative regulation of cysteine-type endopeptidase activity |
| GO:0043085 | 5.77% | positive regulation of catalytic activity |
| GO:0071216 | 5.76% | cellular response to biotic stimulus |
| GO:0104004 | 5.76% | cellular response to environmental stimulus |
| GO:0051234 | 5.74% | establishment of localization |
| GO:0071214 | 5.69% | cellular response to abiotic stimulus |
| GO:0010608 | 5.68% | posttranscriptional regulation of gene expression |
| GO:0042594 | 5.68% | response to starvation |
| GO:0002694 | 5.67% | regulation of leukocyte activation |
| GO:0150077 | 5.67% | regulation of neuroinflammatory response |
| GO:0051179 | 5.60% | localization |
| GO:0071345 | 5.59% | cellular response to cytokine stimulus |
| GO:0031641 | 5.56% | regulation of myelination |
| GO:0007169 | 5.55% | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0001558 | 5.54% | regulation of cell growth |
| GO:2000241 | 5.52% | regulation of reproductive process |
| GO:0046427 | 5.52% | positive regulation of receptor signaling pathway via JAK-STAT |
| GO:0048870 | 5.50% | cell motility |
| GO:0032757 | 5.49% | positive regulation of interleukin-8 production |
| GO:0043030 | 5.49% | regulation of macrophage activation |
| GO:0050673 | 5.45% | epithelial cell proliferation |
| GO:0008544 | 5.44% | epidermis development |
| GO:0006919 | 5.44% | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0046483 | 5.42% | heterocycle metabolic process |
| GO:0006807 | 5.41% | nitrogen compound metabolic process |
| GO:0048534 | 5.41% | hematopoietic or lymphoid organ development |
| GO:0050865 | 5.40% | regulation of cell activation |
| GO:0044238 | 5.40% | primary metabolic process |
| GO:0051881 | 5.39% | regulation of mitochondrial membrane potential |
| GO:0045927 | 5.39% | positive regulation of growth |
| GO:2000242 | 5.39% | negative regulation of reproductive process |
| GO:0048731 | 5.36% | system development |
| GO:1903706 | 5.35% | regulation of hemopoiesis |
| GO:0034644 | 5.35% | cellular response to UV |
| GO:1903508 | 5.30% | positive regulation of nucleic acid-templated transcription |
| GO:0031331 | 5.29% | positive regulation of cellular catabolic process |
| GO:0010955 | 5.28% | negative regulation of protein processing |
| GO:0034612 | 5.28% | response to tumor necrosis factor |
| GO:1902680 | 5.27% | positive regulation of RNA biosynthetic process |
| GO:0045321 | 5.26% | leukocyte activation |
| GO:0071542 | 5.26% | dopaminergic neuron differentiation |
| GO:0030099 | 5.25% | myeloid cell differentiation |
| GO:0045893 | 5.24% | positive regulation of transcription, DNA-templated |
| GO:0090304 | 5.23% | nucleic acid metabolic process |
| GO:0010927 | 5.22% | cellular component assembly involved in morphogenesis |
| GO:1904894 | 5.21% | positive regulation of receptor signaling pathway via STAT |
| GO:1903318 | 5.21% | negative regulation of protein maturation |
| GO:0010948 | 5.20% | negative regulation of cell cycle process |
| GO:0043933 | 5.20% | protein-containing complex subunit organization |
| GO:0019216 | 5.20% | regulation of lipid metabolic process |
| GO:1901654 | 5.18% | response to ketone |
| GO:0071396 | 5.17% | cellular response to lipid |
| GO:0048145 | 5.17% | regulation of fibroblast proliferation |
| GO:0043524 | 5.16% | negative regulation of neuron apoptotic process |
| GO:0001938 | 5.14% | positive regulation of endothelial cell proliferation |
| GO:0070555 | 5.12% | response to interleukin-1 |
| GO:2001233 | 5.12% | regulation of apoptotic signaling pathway |
| GO:0072593 | 5.10% | reactive oxygen species metabolic process |
| GO:0048565 | 5.10% | digestive tract development |
| GO:0002702 | 5.07% | positive regulation of production of molecular mediator of immune response |
| GO:0006986 | 5.04% | response to unfolded protein |
| GO:0048872 | 5.03% | homeostasis of number of cells |
| GO:0051726 | 5.03% | regulation of cell cycle |
| GO:0007275 | 5.02% | multicellular organism development |
| GO:0043523 | 5.02% | regulation of neuron apoptotic process |
| GO:0009896 | 5.02% | positive regulation of catabolic process |
| GO:0032098 | 5.01% | regulation of appetite |
| GO:1903205 | 5.01% | regulation of hydrogen peroxide-induced cell death |
| GO:0071456 | 4.98% | cellular response to hypoxia |
| GO:0006629 | 4.97% | lipid metabolic process |
| GO:0065003 | 4.97% | protein-containing complex assembly |
| GO:0007600 | 4.95% | sensory perception |
| GO:0051930 | 4.94% | regulation of sensory perception of pain |
| GO:0071356 | 4.93% | cellular response to tumor necrosis factor |
| GO:0051385 | 4.93% | response to mineralocorticoid |
| GO:0018958 | 4.93% | phenol-containing compound metabolic process |
| GO:0016070 | 4.93% | RNA metabolic process |
| GO:0010975 | 4.92% | regulation of neuron projection development |
| GO:0071478 | 4.90% | cellular response to radiation |
| GO:0051302 | 4.90% | regulation of cell division |
| GO:0044764 | 4.89% | multi-organism cellular process |
| GO:0051338 | 4.89% | regulation of transferase activity |
| GO:0019835 | 4.87% | cytolysis |
| GO:0045637 | 4.85% | regulation of myeloid cell differentiation |
| GO:0010038 | 4.85% | response to metal ion |
| GO:0035556 | 4.85% | intracellular signal transduction |
| GO:0032879 | 4.81% | regulation of localization |
| GO:0045187 | 4.81% | regulation of circadian sleep/wake cycle, sleep |
| GO:2000278 | 4.80% | regulation of DNA biosynthetic process |
| GO:0007186 | 4.80% | G protein-coupled receptor signaling pathway |
| GO:0045333 | 4.79% | cellular respiration |
| GO:0002449 | 4.78% | lymphocyte mediated immunity |
| GO:0090329 | 4.77% | regulation of DNA-dependent DNA replication |
| GO:0022600 | 4.76% | digestive system process |
| GO:0050890 | 4.76% | cognition |
| GO:0050810 | 4.76% | regulation of steroid biosynthetic process |
| GO:0051591 | 4.75% | response to cAMP |
| GO:0030534 | 4.75% | adult behavior |
| GO:0031344 | 4.75% | regulation of cell projection organization |
| GO:0051347 | 4.74% | positive regulation of transferase activity |
| GO:0016525 | 4.73% | negative regulation of angiogenesis |
| GO:0002695 | 4.73% | negative regulation of leukocyte activation |
| GO:0010558 | 4.73% | negative regulation of macromolecule biosynthetic process |
| GO:0001889 | 4.72% | liver development |
| GO:0071229 | 4.72% | cellular response to acid chemical |
| GO:0120035 | 4.72% | regulation of plasma membrane bounded cell projection organization |
| GO:0042698 | 4.72% | ovulation cycle |
| GO:0031334 | 4.71% | positive regulation of protein complex assembly |
| GO:0016477 | 4.70% | cell migration |
| GO:0007631 | 4.70% | feeding behavior |
| GO:0010165 | 4.69% | response to X-ray |
| GO:0040014 | 4.69% | regulation of multicellular organism growth |
| GO:0009612 | 4.68% | response to mechanical stimulus |
| GO:1903555 | 4.68% | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0006139 | 4.68% | nucleobase-containing compound metabolic process |
| GO:0045765 | 4.68% | regulation of angiogenesis |
| GO:0071219 | 4.68% | cellular response to molecule of bacterial origin |
| GO:2001235 | 4.66% | positive regulation of apoptotic signaling pathway |
| GO:0032989 | 4.65% | cellular component morphogenesis |
| GO:0036294 | 4.65% | cellular response to decreased oxygen levels |
| GO:0007160 | 4.64% | cell-matrix adhesion |
| GO:0051931 | 4.63% | regulation of sensory perception |
| GO:0032870 | 4.63% | cellular response to hormone stimulus |
| GO:0030182 | 4.62% | neuron differentiation |
| GO:0034641 | 4.59% | cellular nitrogen compound metabolic process |
| GO:0045664 | 4.59% | regulation of neuron differentiation |
| GO:2001038 | 4.59% | regulation of cellular response to drug |
| GO:0097190 | 4.58% | apoptotic signaling pathway |
| GO:0042749 | 4.58% | regulation of circadian sleep/wake cycle |
| GO:0009566 | 4.57% | fertilization |
| GO:0001936 | 4.55% | regulation of endothelial cell proliferation |
| GO:0009620 | 4.54% | response to fungus |
| GO:0090305 | 4.53% | nucleic acid phosphodiester bond hydrolysis |
| GO:0007605 | 4.52% | sensory perception of sound |
| GO:0006508 | 4.52% | proteolysis |
| GO:0006091 | 4.52% | generation of precursor metabolites and energy |
| GO:1901342 | 4.52% | regulation of vasculature development |
| GO:0072089 | 4.49% | stem cell proliferation |
| GO:0019098 | 4.49% | reproductive behavior |
| GO:1903859 | 4.47% | regulation of dendrite extension |
| GO:0002521 | 4.47% | leukocyte differentiation |
| GO:0007626 | 4.47% | locomotory behavior |
| GO:0046425 | 4.47% | regulation of receptor signaling pathway via JAK-STAT |
| GO:0051852 | 4.47% | disruption by host of symbiont cells |
| GO:0008344 | 4.46% | adult locomotory behavior |
| GO:0006996 | 4.46% | organelle organization |
| GO:2000181 | 4.44% | negative regulation of blood vessel morphogenesis |
| GO:0031640 | 4.44% | killing of cells of other organism |
| GO:0042752 | 4.44% | regulation of circadian rhythm |
| GO:1904892 | 4.43% | regulation of receptor signaling pathway via STAT |
| GO:0032722 | 4.43% | positive regulation of chemokine production |
| GO:0035295 | 4.42% | tube development |
| GO:0046890 | 4.42% | regulation of lipid biosynthetic process |
| GO:1901343 | 4.41% | negative regulation of vasculature development |
| GO:0006457 | 4.39% | protein folding |
| GO:0023057 | 4.39% | negative regulation of signaling |
| GO:0010212 | 4.39% | response to ionizing radiation |
| GO:0050866 | 4.39% | negative regulation of cell activation |
| GO:0031099 | 4.39% | regeneration |
| GO:0002274 | 4.38% | myeloid leukocyte activation |
| GO:0032103 | 4.37% | positive regulation of response to external stimulus |
| GO:0035966 | 4.36% | response to topologically incorrect protein |
| GO:0030878 | 4.36% | thyroid gland development |
| GO:0051784 | 4.35% | negative regulation of nuclear division |
| GO:1901564 | 4.35% | organonitrogen compound metabolic process |
| GO:0045944 | 4.35% | positive regulation of transcription by RNA polymerase II |
| GO:0048589 | 4.35% | developmental growth |
| GO:0045934 | 4.34% | negative regulation of nucleobase-containing compound metabolic process |
| GO:0048878 | 4.33% | chemical homeostasis |
| GO:2000377 | 4.33% | regulation of reactive oxygen species metabolic process |
| GO:0033363 | 4.32% | secretory granule organization |
| GO:0044706 | 4.32% | multi-multicellular organism process |
| GO:0051873 | 4.32% | killing by host of symbiont cells |
| GO:0010648 | 4.32% | negative regulation of cell communication |
| GO:0043281 | 4.31% | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0043254 | 4.30% | regulation of protein complex assembly |
| GO:2000113 | 4.30% | negative regulation of cellular macromolecule biosynthetic process |
| GO:0015980 | 4.30% | energy derivation by oxidation of organic compounds |
| GO:1901031 | 4.30% | regulation of response to reactive oxygen species |
| GO:0006974 | 4.29% | cellular response to DNA damage stimulus |
| GO:1903201 | 4.28% | regulation of oxidative stress-induced cell death |
| GO:0060259 | 4.28% | regulation of feeding behavior |
| GO:0031349 | 4.27% | positive regulation of defense response |
| GO:0071347 | 4.26% | cellular response to interleukin-1 |
| GO:0006357 | 4.26% | regulation of transcription by RNA polymerase II |
| GO:0002067 | 4.26% | glandular epithelial cell differentiation |
| GO:0009267 | 4.25% | cellular response to starvation |
| GO:0043549 | 4.24% | regulation of kinase activity |
| GO:1903861 | 4.24% | positive regulation of dendrite extension |
| GO:0045926 | 4.22% | negative regulation of growth |
| GO:0048863 | 4.22% | stem cell differentiation |
| GO:0009056 | 4.21% | catabolic process |
| GO:0044364 | 4.20% | disruption of cells of other organism |
| GO:0051090 | 4.20% | regulation of DNA-binding transcription factor activity |
| GO:0017148 | 4.19% | negative regulation of translation |
| GO:0007584 | 4.19% | response to nutrient |
| GO:0050832 | 4.19% | defense response to fungus |
| GO:0019538 | 4.18% | protein metabolic process |
| GO:0010817 | 4.17% | regulation of hormone levels |
| GO:0002699 | 4.15% | positive regulation of immune effector process |
| GO:0009755 | 4.15% | hormone-mediated signaling pathway |
| GO:0040007 | 4.15% | growth |
| GO:0044703 | 4.15% | multi-organism reproductive process |
| GO:0050729 | 4.14% | positive regulation of inflammatory response |
| GO:0050954 | 4.14% | sensory perception of mechanical stimulus |
| GO:0055114 | 4.14% | oxidation-reduction process |
| GO:1902105 | 4.13% | regulation of leukocyte differentiation |
| GO:0009408 | 4.13% | response to heat |
| GO:1901615 | 4.13% | organic hydroxy compound metabolic process |
| GO:0051091 | 4.13% | positive regulation of DNA-binding transcription factor activity |
| GO:0031100 | 4.11% | animal organ regeneration |
| GO:0006109 | 4.10% | regulation of carbohydrate metabolic process |
| GO:0007049 | 4.09% | cell cycle |
| GO:0051193 | 4.09% | regulation of cofactor metabolic process |
| GO:0030307 | 4.07% | positive regulation of cell growth |
| GO:0007417 | 4.07% | central nervous system development |
| GO:0009790 | 4.06% | embryo development |
| GO:0051818 | 4.06% | disruption of cells of other organism involved in symbiotic interaction |
| GO:0007005 | 4.06% | mitochondrion organization |
| GO:0042391 | 4.05% | regulation of membrane potential |
| GO:0010669 | 4.05% | epithelial structure maintenance |
| GO:0061351 | 4.05% | neural precursor cell proliferation |
| GO:0006417 | 4.04% | regulation of translation |
| GO:0045859 | 4.03% | regulation of protein kinase activity |
| GO:1903557 | 4.02% | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0010564 | 4.02% | regulation of cell cycle process |
| GO:0045471 | 4.02% | response to ethanol |
| GO:0046649 | 4.01% | lymphocyte activation |
| GO:0097421 | 4.01% | liver regeneration |
| GO:0071222 | 4.01% | cellular response to lipopolysaccharide |
| GO:0032680 | 4.00% | regulation of tumor necrosis factor production |
| GO:1903202 | 4.00% | negative regulation of oxidative stress-induced cell death |
| GO:0019731 | 3.99% | antibacterial humoral response |
| GO:0006468 | 3.98% | protein phosphorylation |
| GO:0022904 | 3.98% | respiratory electron transport chain |
| GO:2000177 | 3.98% | regulation of neural precursor cell proliferation |
| GO:0048017 | 3.98% | inositol lipid-mediated signaling |
| GO:0033574 | 3.97% | response to testosterone |
| GO:0045639 | 3.96% | positive regulation of myeloid cell differentiation |
| GO:0048639 | 3.96% | positive regulation of developmental growth |
| GO:0009411 | 3.96% | response to UV |
| GO:1900407 | 3.95% | regulation of cellular response to oxidative stress |
| GO:0051883 | 3.94% | killing of cells in other organism involved in symbiotic interaction |
| GO:0051054 | 3.94% | positive regulation of DNA metabolic process |
| GO:0044248 | 3.93% | cellular catabolic process |
| GO:0071900 | 3.92% | regulation of protein serine/threonine kinase activity |
| GO:1903203 | 3.92% | regulation of oxidative stress-induced neuron death |
| GO:0007611 | 3.91% | learning or memory |
| GO:0002684 | 3.91% | positive regulation of immune system process |
| GO:0071417 | 3.90% | cellular response to organonitrogen compound |
| GO:0032094 | 3.90% | response to food |
| GO:0007617 | 3.90% | mating behavior |
| GO:0007219 | 3.90% | Notch signaling pathway |
| GO:0010952 | 3.88% | positive regulation of peptidase activity |
| GO:0045834 | 3.88% | positive regulation of lipid metabolic process |
| GO:0014074 | 3.88% | response to purine-containing compound |
| GO:0050730 | 3.87% | regulation of peptidyl-tyrosine phosphorylation |
| GO:0043393 | 3.87% | regulation of protein binding |
| GO:0042060 | 3.87% | wound healing |
| GO:0008217 | 3.87% | regulation of blood pressure |
| GO:0032981 | 3.87% | mitochondrial respiratory chain complex I assembly |
| GO:1900408 | 3.86% | negative regulation of cellular response to oxidative stress |
| GO:0044087 | 3.85% | regulation of cellular component biogenesis |
| GO:1901099 | 3.85% | negative regulation of signal transduction in absence of ligand |
| GO:0034284 | 3.84% | response to monosaccharide |
| GO:0014065 | 3.84% | phosphatidylinositol 3-kinase signaling |
| GO:0002460 | 3.84% | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0003013 | 3.84% | circulatory system process |
| GO:0010906 | 3.84% | regulation of glucose metabolic process |
| GO:0016310 | 3.83% | phosphorylation |
| GO:0003012 | 3.83% | muscle system process |
| GO:0010810 | 3.79% | regulation of cell-substrate adhesion |
| GO:0009968 | 3.79% | negative regulation of signal transduction |
| GO:1901987 | 3.78% | regulation of cell cycle phase transition |
| GO:2001039 | 3.78% | negative regulation of cellular response to drug |
| GO:0009792 | 3.78% | embryo development ending in birth or egg hatching |
| GO:0019218 | 3.77% | regulation of steroid metabolic process |
| GO:0030097 | 3.76% | hemopoiesis |
| GO:0044089 | 3.76% | positive regulation of cellular component biogenesis |
| GO:0050878 | 3.76% | regulation of body fluid levels |
| GO:0048521 | 3.76% | negative regulation of behavior |
| GO:0090066 | 3.75% | regulation of anatomical structure size |
| GO:0034249 | 3.74% | negative regulation of cellular amide metabolic process |
| GO:0033043 | 3.74% | regulation of organelle organization |
| GO:0009746 | 3.73% | response to hexose |
| GO:0022610 | 3.73% | biological adhesion |
| GO:0043627 | 3.71% | response to estrogen |
| GO:0034622 | 3.71% | cellular protein-containing complex assembly |
| GO:0022900 | 3.70% | electron transport chain |
| GO:0046620 | 3.70% | regulation of organ growth |
| GO:0002784 | 3.70% | regulation of antimicrobial peptide production |
| GO:0051896 | 3.69% | regulation of protein kinase B signaling |
| GO:0061024 | 3.68% | membrane organization |
| GO:0090659 | 3.68% | walking behavior |
| GO:0051817 | 3.68% | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0042445 | 3.67% | hormone metabolic process |
| GO:0030278 | 3.67% | regulation of ossification |
| GO:0010950 | 3.67% | positive regulation of endopeptidase activity |
| GO:0043900 | 3.67% | regulation of multi-organism process |
| GO:0006351 | 3.66% | transcription, DNA-templated |
| GO:0033273 | 3.66% | response to vitamin |
| GO:0040013 | 3.65% | negative regulation of locomotion |
| GO:1901699 | 3.65% | cellular response to nitrogen compound |
| GO:0051345 | 3.65% | positive regulation of hydrolase activity |
| GO:0045596 | 3.64% | negative regulation of cell differentiation |
| GO:0071482 | 3.64% | cellular response to light stimulus |
| GO:0046903 | 3.63% | secretion |
| GO:0002700 | 3.63% | regulation of production of molecular mediator of immune response |
| GO:2001056 | 3.62% | positive regulation of cysteine-type endopeptidase activity |
| GO:0061013 | 3.62% | regulation of mRNA catabolic process |
| GO:0030098 | 3.62% | lymphocyte differentiation |
| GO:2001240 | 3.62% | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0031670 | 3.62% | cellular response to nutrient |
| GO:0051702 | 3.62% | interaction with symbiont |
| GO:0043280 | 3.62% | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0051607 | 3.60% | defense response to virus |
| GO:0010821 | 3.59% | regulation of mitochondrion organization |
| GO:0097659 | 3.59% | nucleic acid-templated transcription |
| GO:0033138 | 3.59% | positive regulation of peptidyl-serine phosphorylation |
| GO:0030334 | 3.59% | regulation of cell migration |
| GO:0030856 | 3.59% | regulation of epithelial cell differentiation |
| GO:0051098 | 3.59% | regulation of binding |
| GO:1902882 | 3.59% | regulation of response to oxidative stress |
| GO:0043487 | 3.58% | regulation of RNA stability |
| GO:0009615 | 3.58% | response to virus |
| GO:0051412 | 3.57% | response to corticosterone |
| GO:0019725 | 3.57% | cellular homeostasis |
| GO:0009058 | 3.57% | biosynthetic process |
| GO:0032091 | 3.57% | negative regulation of protein binding |
| GO:0040012 | 3.56% | regulation of locomotion |
| GO:0097191 | 3.55% | extrinsic apoptotic signaling pathway |
| GO:2001236 | 3.55% | regulation of extrinsic apoptotic signaling pathway |
| GO:0050731 | 3.54% | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:2000145 | 3.54% | regulation of cell motility |
| GO:1902532 | 3.54% | negative regulation of intracellular signal transduction |
| GO:0001525 | 3.54% | angiogenesis |
| GO:1900117 | 3.54% | regulation of execution phase of apoptosis |
| GO:0021987 | 3.53% | cerebral cortex development |
| GO:0001541 | 3.53% | ovarian follicle development |
| GO:0071695 | 3.52% | anatomical structure maturation |
| GO:0009749 | 3.52% | response to glucose |
| GO:1903311 | 3.52% | regulation of mRNA metabolic process |
| GO:2001239 | 3.51% | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0007155 | 3.50% | cell adhesion |
| GO:0022604 | 3.50% | regulation of cell morphogenesis |
| GO:0010758 | 3.49% | regulation of macrophage chemotaxis |
| GO:0033500 | 3.49% | carbohydrate homeostasis |
| GO:1904018 | 3.49% | positive regulation of vasculature development |
| GO:1902883 | 3.49% | negative regulation of response to oxidative stress |
| GO:0055093 | 3.49% | response to hyperoxia |
| GO:1903998 | 3.48% | regulation of eating behavior |
| GO:0051781 | 3.48% | positive regulation of cell division |
| GO:0007346 | 3.48% | regulation of mitotic cell cycle |
| GO:0044260 | 3.48% | cellular macromolecule metabolic process |
| GO:0071346 | 3.47% | cellular response to interferon-gamma |
| GO:0010811 | 3.47% | positive regulation of cell-substrate adhesion |
| GO:0001818 | 3.47% | negative regulation of cytokine production |
| GO:0008637 | 3.47% | apoptotic mitochondrial changes |
| GO:0030218 | 3.47% | erythrocyte differentiation |
| GO:0048666 | 3.46% | neuron development |
| GO:0046683 | 3.46% | response to organophosphorus |
| GO:0033189 | 3.46% | response to vitamin A |
| GO:0007628 | 3.45% | adult walking behavior |
| GO:0007565 | 3.45% | female pregnancy |
| GO:0048580 | 3.44% | regulation of post-embryonic development |
| GO:0010565 | 3.44% | regulation of cellular ketone metabolic process |
| GO:0050680 | 3.44% | negative regulation of epithelial cell proliferation |
| GO:2000648 | 3.43% | positive regulation of stem cell proliferation |
| GO:0042403 | 3.43% | thyroid hormone metabolic process |
| GO:0035902 | 3.42% | response to immobilization stress |
| GO:0034248 | 3.42% | regulation of cellular amide metabolic process |
| GO:1903429 | 3.42% | regulation of cell maturation |
| GO:0032755 | 3.42% | positive regulation of interleukin-6 production |
| GO:2001023 | 3.42% | regulation of response to drug |
| GO:1902806 | 3.40% | regulation of cell cycle G1/S phase transition |
| GO:0044255 | 3.39% | cellular lipid metabolic process |
| GO:0050953 | 3.39% | sensory perception of light stimulus |
| GO:0031175 | 3.39% | neuron projection development |
| GO:0010257 | 3.39% | NADH dehydrogenase complex assembly |
| GO:0072091 | 3.38% | regulation of stem cell proliferation |
| GO:0001822 | 3.38% | kidney development |
| GO:0033674 | 3.38% | positive regulation of kinase activity |
| GO:0007586 | 3.38% | digestion |
| GO:0071827 | 3.38% | plasma lipoprotein particle organization |
| GO:0002761 | 3.38% | regulation of myeloid leukocyte differentiation |
| GO:0010639 | 3.37% | negative regulation of organelle organization |
| GO:0032642 | 3.37% | regulation of chemokine production |
| GO:0031589 | 3.37% | cell-substrate adhesion |
| GO:0008610 | 3.37% | lipid biosynthetic process |
| GO:0048520 | 3.36% | positive regulation of behavior |
| GO:0062013 | 3.36% | positive regulation of small molecule metabolic process |
| GO:0098781 | 3.36% | ncRNA transcription |
| GO:0043488 | 3.36% | regulation of mRNA stability |
| GO:0002251 | 3.36% | organ or tissue specific immune response |
| GO:0051049 | 3.36% | regulation of transport |
| GO:0045766 | 3.36% | positive regulation of angiogenesis |
| GO:0070584 | 3.35% | mitochondrion morphogenesis |
| GO:0051897 | 3.35% | positive regulation of protein kinase B signaling |
| GO:0008625 | 3.35% | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:2000573 | 3.35% | positive regulation of DNA biosynthetic process |
| GO:0051592 | 3.35% | response to calcium ion |
| GO:0036296 | 3.35% | response to increased oxygen levels |
| GO:0010634 | 3.35% | positive regulation of epithelial cell migration |
| GO:0061458 | 3.34% | reproductive system development |
| GO:0043902 | 3.34% | positive regulation of multi-organism process |
| GO:0043009 | 3.34% | chordate embryonic development |
| GO:0050994 | 3.34% | regulation of lipid catabolic process |
| GO:0032675 | 3.34% | regulation of interleukin-6 production |
| GO:0007589 | 3.34% | body fluid secretion |
| GO:2000146 | 3.34% | negative regulation of cell motility |
| GO:0045661 | 3.33% | regulation of myoblast differentiation |
| GO:0061138 | 3.32% | morphogenesis of a branching epithelium |
| GO:0007422 | 3.32% | peripheral nervous system development |
| GO:0051270 | 3.32% | regulation of cellular component movement |
| GO:0120161 | 3.32% | regulation of cold-induced thermogenesis |
| GO:0043401 | 3.32% | steroid hormone mediated signaling pathway |
| GO:0002920 | 3.32% | regulation of humoral immune response |
| GO:0007601 | 3.30% | visual perception |
| GO:1900076 | 3.30% | regulation of cellular response to insulin stimulus |
| GO:1903034 | 3.30% | regulation of response to wounding |
| GO:0034341 | 3.30% | response to interferon-gamma |
| GO:0007338 | 3.30% | single fertilization |
| GO:0070542 | 3.30% | response to fatty acid |
| GO:0033135 | 3.29% | regulation of peptidyl-serine phosphorylation |
| GO:0001763 | 3.29% | morphogenesis of a branching structure |
| GO:0009914 | 3.29% | hormone transport |
| GO:0046879 | 3.29% | hormone secretion |
| GO:0010675 | 3.28% | regulation of cellular carbohydrate metabolic process |
| GO:0051253 | 3.27% | negative regulation of RNA metabolic process |
| GO:0048660 | 3.26% | regulation of smooth muscle cell proliferation |
| GO:0010507 | 3.26% | negative regulation of autophagy |
| GO:0045940 | 3.26% | positive regulation of steroid metabolic process |
| GO:0048015 | 3.26% | phosphatidylinositol-mediated signaling |
| GO:0006582 | 3.26% | melanin metabolic process |
| GO:0002759 | 3.26% | regulation of antimicrobial humoral response |
| GO:0033032 | 3.26% | regulation of myeloid cell apoptotic process |
| GO:0042593 | 3.26% | glucose homeostasis |
| GO:0009791 | 3.26% | post-embryonic development |
| GO:0032940 | 3.26% | secretion by cell |
| GO:0042531 | 3.25% | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0044249 | 3.25% | cellular biosynthetic process |
| GO:0001709 | 3.23% | cell fate determination |
| GO:0051260 | 3.23% | protein homooligomerization |
| GO:0032760 | 3.23% | positive regulation of tumor necrosis factor production |
| GO:0007606 | 3.23% | sensory perception of chemical stimulus |
| GO:0042509 | 3.23% | regulation of tyrosine phosphorylation of STAT protein |
| GO:0030879 | 3.22% | mammary gland development |
| GO:2000045 | 3.21% | regulation of G1/S transition of mitotic cell cycle |
| GO:0010893 | 3.21% | positive regulation of steroid biosynthetic process |
| GO:0017144 | 3.20% | drug metabolic process |
| GO:0014823 | 3.20% | response to activity |
| GO:0051271 | 3.20% | negative regulation of cellular component movement |
| GO:0045860 | 3.20% | positive regulation of protein kinase activity |
| GO:0030030 | 3.20% | cell projection organization |
| GO:1901990 | 3.19% | regulation of mitotic cell cycle phase transition |
| GO:0007612 | 3.19% | learning |
| GO:2000379 | 3.19% | positive regulation of reactive oxygen species metabolic process |
| GO:0098743 | 3.19% | cell aggregation |
| GO:0045598 | 3.18% | regulation of fat cell differentiation |
| GO:0030518 | 3.18% | intracellular steroid hormone receptor signaling pathway |
| GO:0010632 | 3.18% | regulation of epithelial cell migration |
| GO:0043200 | 3.18% | response to amino acid |
| GO:0120162 | 3.17% | positive regulation of cold-induced thermogenesis |
| GO:0042440 | 3.17% | pigment metabolic process |
| GO:0002250 | 3.17% | adaptive immune response |
| GO:2000243 | 3.16% | positive regulation of reproductive process |
| GO:0055088 | 3.16% | lipid homeostasis |
| GO:1903708 | 3.16% | positive regulation of hemopoiesis |
| GO:0040018 | 3.16% | positive regulation of multicellular organism growth |
| GO:0043405 | 3.16% | regulation of MAP kinase activity |
| GO:0006970 | 3.15% | response to osmotic stress |
| GO:0043467 | 3.14% | regulation of generation of precursor metabolites and energy |
| GO:1901575 | 3.14% | organic substance catabolic process |
| GO:0090501 | 3.13% | RNA phosphodiester bond hydrolysis |
| GO:0070848 | 3.13% | response to growth factor |
| GO:0002639 | 3.12% | positive regulation of immunoglobulin production |
| GO:0001503 | 3.11% | ossification |
| GO:0071407 | 3.11% | cellular response to organic cyclic compound |
| GO:0032774 | 3.11% | RNA biosynthetic process |
| GO:0034655 | 3.10% | nucleobase-containing compound catabolic process |
| GO:0051051 | 3.10% | negative regulation of transport |
| GO:0002697 | 3.10% | regulation of immune effector process |
| GO:2001234 | 3.09% | negative regulation of apoptotic signaling pathway |
| GO:0051851 | 3.09% | modification by host of symbiont morphology or physiology |
| GO:2000105 | 3.09% | positive regulation of DNA-dependent DNA replication |
| GO:0043901 | 3.08% | negative regulation of multi-organism process |
| GO:0048640 | 3.08% | negative regulation of developmental growth |
| GO:0090287 | 3.08% | regulation of cellular response to growth factor stimulus |
| GO:0032104 | 3.08% | regulation of response to extracellular stimulus |
| GO:0045777 | 3.08% | positive regulation of blood pressure |
| GO:0032965 | 3.07% | regulation of collagen biosynthetic process |
| GO:0006909 | 3.07% | phagocytosis |
| GO:0018209 | 3.07% | peptidyl-serine modification |
| GO:0045839 | 3.07% | negative regulation of mitotic nuclear division |
| GO:0051092 | 3.06% | positive regulation of NF-kappaB transcription factor activity |
| GO:0014068 | 3.06% | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0072331 | 3.06% | signal transduction by p53 class mediator |
| GO:0071322 | 3.06% | cellular response to carbohydrate stimulus |
| GO:0002922 | 3.05% | positive regulation of humoral immune response |
| GO:0038034 | 3.05% | signal transduction in absence of ligand |
| GO:0042119 | 3.05% | neutrophil activation |
| GO:0001667 | 3.05% | ameboidal-type cell migration |
| GO:1901532 | 3.05% | regulation of hematopoietic progenitor cell differentiation |
| GO:0014066 | 3.04% | regulation of phosphatidylinositol 3-kinase signaling |
| GO:2001024 | 3.04% | negative regulation of response to drug |
| GO:0051186 | 3.04% | cofactor metabolic process |
| GO:0043062 | 3.04% | extracellular structure organization |
| GO:0097192 | 3.04% | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0009409 | 3.03% | response to cold |
| GO:0030336 | 3.03% | negative regulation of cell migration |
| GO:0097193 | 3.03% | intrinsic apoptotic signaling pathway |
| GO:0071260 | 3.02% | cellular response to mechanical stimulus |
| GO:0010039 | 3.02% | response to iron ion |
| GO:0032107 | 3.02% | regulation of response to nutrient levels |
| GO:1904407 | 3.01% | positive regulation of nitric oxide metabolic process |
| GO:0120036 | 3.01% | plasma membrane bounded cell projection organization |
| GO:0046889 | 3.01% | positive regulation of lipid biosynthetic process |
| GO:0006793 | 3.01% | phosphorus metabolic process |
| GO:0030858 | 3.01% | positive regulation of epithelial cell differentiation |
| GO:0034605 | 3.00% | cellular response to heat |
| GO:0071702 | 3.00% | organic substance transport |
| GO:0010638 | 3.00% | positive regulation of organelle organization |
| GO:0051046 | 2.99% | regulation of secretion |
| GO:0090559 | 2.99% | regulation of membrane permeability |
| GO:0001678 | 2.98% | cellular glucose homeostasis |
| GO:0010677 | 2.98% | negative regulation of cellular carbohydrate metabolic process |
| GO:0045619 | 2.98% | regulation of lymphocyte differentiation |
| GO:0098916 | 2.98% | anterograde trans-synaptic signaling |
| GO:1905521 | 2.98% | regulation of macrophage migration |
| GO:0034368 | 2.95% | protein-lipid complex remodeling |
| GO:0042100 | 2.95% | B cell proliferation |
| GO:0006721 | 2.94% | terpenoid metabolic process |
| GO:0045833 | 2.94% | negative regulation of lipid metabolic process |
| GO:0070098 | 2.94% | chemokine-mediated signaling pathway |
| GO:0071333 | 2.94% | cellular response to glucose stimulus |
| GO:0022612 | 2.94% | gland morphogenesis |
| GO:0048641 | 2.94% | regulation of skeletal muscle tissue development |
| GO:0030198 | 2.94% | extracellular matrix organization |
| GO:0006796 | 2.93% | phosphate-containing compound metabolic process |
| GO:0030855 | 2.93% | epithelial cell differentiation |
| GO:0048729 | 2.92% | tissue morphogenesis |
| GO:0051100 | 2.92% | negative regulation of binding |
| GO:0140352 | 2.91% | export from cell |
| GO:1901576 | 2.91% | organic substance biosynthetic process |
| GO:0071479 | 2.91% | cellular response to ionizing radiation |
| GO:0055090 | 2.90% | acylglycerol homeostasis |
| GO:0010714 | 2.90% | positive regulation of collagen metabolic process |
| GO:1902369 | 2.90% | negative regulation of RNA catabolic process |
| GO:0045923 | 2.90% | positive regulation of fatty acid metabolic process |
| GO:0048568 | 2.89% | embryonic organ development |
| GO:0008306 | 2.89% | associative learning |
| GO:0036230 | 2.88% | granulocyte activation |
| GO:0002637 | 2.88% | regulation of immunoglobulin production |
| GO:0062014 | 2.87% | negative regulation of small molecule metabolic process |
| GO:0043123 | 2.87% | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0070328 | 2.87% | triglyceride homeostasis |
| GO:0007389 | 2.86% | pattern specification process |
| GO:0099537 | 2.86% | trans-synaptic signaling |
| GO:0071230 | 2.86% | cellular response to amino acid stimulus |
| GO:0050777 | 2.85% | negative regulation of immune response |
| GO:0043032 | 2.85% | positive regulation of macrophage activation |
| GO:0042330 | 2.85% | taxis |
| GO:1903672 | 2.85% | positive regulation of sprouting angiogenesis |
| GO:0019722 | 2.84% | calcium-mediated signaling |
| GO:0019439 | 2.83% | aromatic compound catabolic process |
| GO:0001523 | 2.83% | retinoid metabolic process |
| GO:0032653 | 2.83% | regulation of interleukin-10 production |
| GO:0008340 | 2.82% | determination of adult lifespan |
| GO:0010822 | 2.81% | positive regulation of mitochondrion organization |
| GO:0046686 | 2.81% | response to cadmium ion |
| GO:0051289 | 2.80% | protein homotetramerization |
| GO:0007268 | 2.80% | chemical synaptic transmission |
| GO:0044265 | 2.80% | cellular macromolecule catabolic process |
| GO:0048598 | 2.80% | embryonic morphogenesis |
| GO:0051259 | 2.79% | protein complex oligomerization |
| GO:0043271 | 2.79% | negative regulation of ion transport |
| GO:0090200 | 2.79% | positive regulation of release of cytochrome c from mitochondria |
| GO:0051050 | 2.79% | positive regulation of transport |
| GO:0061041 | 2.78% | regulation of wound healing |
| GO:1901361 | 2.78% | organic cyclic compound catabolic process |
| GO:0015850 | 2.77% | organic hydroxy compound transport |
| GO:0007608 | 2.76% | sensory perception of smell |
| GO:0042417 | 2.76% | dopamine metabolic process |
| GO:0045646 | 2.76% | regulation of erythrocyte differentiation |
| GO:0007399 | 2.76% | nervous system development |
| GO:1990830 | 2.75% | cellular response to leukemia inhibitory factor |
| GO:0070661 | 2.75% | leukocyte proliferation |
| GO:0042136 | 2.75% | neurotransmitter biosynthetic process |
| GO:0032990 | 2.75% | cell part morphogenesis |
| GO:0034369 | 2.75% | plasma lipoprotein particle remodeling |
| GO:0045892 | 2.75% | negative regulation of transcription, DNA-templated |
| GO:1903507 | 2.74% | negative regulation of nucleic acid-templated transcription |
| GO:0045454 | 2.74% | cell redox homeostasis |
| GO:0050776 | 2.74% | regulation of immune response |
| GO:0009629 | 2.74% | response to gravity |
| GO:0006120 | 2.74% | mitochondrial electron transport, NADH to ubiquinone |
| GO:1903427 | 2.73% | negative regulation of reactive oxygen species biosynthetic process |
| GO:1902679 | 2.73% | negative regulation of RNA biosynthetic process |
| GO:0032733 | 2.73% | positive regulation of interleukin-10 production |
| GO:0001505 | 2.73% | regulation of neurotransmitter levels |
| GO:0006869 | 2.73% | lipid transport |
| GO:2001238 | 2.72% | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0000902 | 2.72% | cell morphogenesis |
| GO:0009303 | 2.72% | rRNA transcription |
| GO:1900015 | 2.72% | regulation of cytokine production involved in inflammatory response |
| GO:0050864 | 2.72% | regulation of B cell activation |
| GO:0032526 | 2.72% | response to retinoic acid |
| GO:0008630 | 2.71% | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:1902692 | 2.71% | regulation of neuroblast proliferation |
| GO:0016101 | 2.71% | diterpenoid metabolic process |
| GO:1901362 | 2.71% | organic cyclic compound biosynthetic process |
| GO:0010224 | 2.70% | response to UV-B |
| GO:0001701 | 2.70% | in utero embryonic development |
| GO:0097164 | 2.70% | ammonium ion metabolic process |
| GO:0071331 | 2.68% | cellular response to hexose stimulus |
| GO:0033108 | 2.68% | mitochondrial respiratory chain complex assembly |
| GO:0010595 | 2.68% | positive regulation of endothelial cell migration |
| GO:0016485 | 2.68% | protein processing |
| GO:0051604 | 2.68% | protein maturation |
| GO:0070633 | 2.67% | transepithelial transport |
| GO:0032651 | 2.67% | regulation of interleukin-1 beta production |
| GO:0032570 | 2.67% | response to progesterone |
| GO:0071772 | 2.66% | response to BMP |
| GO:0006811 | 2.66% | ion transport |
| GO:0071825 | 2.66% | protein-lipid complex subunit organization |
| GO:0043470 | 2.65% | regulation of carbohydrate catabolic process |
| GO:0007595 | 2.64% | lactation |
| GO:0060627 | 2.64% | regulation of vesicle-mediated transport |
| GO:0051641 | 2.64% | cellular localization |
| GO:0099536 | 2.64% | synaptic signaling |
| GO:0016071 | 2.64% | mRNA metabolic process |
| GO:0061077 | 2.64% | chaperone-mediated protein folding |
| GO:0044281 | 2.64% | small molecule metabolic process |
| GO:0071773 | 2.63% | cellular response to BMP stimulus |
| GO:0042113 | 2.63% | B cell activation |
| GO:0051258 | 2.63% | protein polymerization |
| GO:0051055 | 2.63% | negative regulation of lipid biosynthetic process |
| GO:0044270 | 2.63% | cellular nitrogen compound catabolic process |
| GO:1903362 | 2.63% | regulation of cellular protein catabolic process |
| GO:0045577 | 2.63% | regulation of B cell differentiation |
| GO:0034367 | 2.63% | protein-containing complex remodeling |
| GO:1903426 | 2.63% | regulation of reactive oxygen species biosynthetic process |
| GO:0007613 | 2.62% | memory |
| GO:0030155 | 2.62% | regulation of cell adhesion |
| GO:0050900 | 2.62% | leukocyte migration |
| GO:0071326 | 2.62% | cellular response to monosaccharide stimulus |
| GO:0032967 | 2.62% | positive regulation of collagen biosynthetic process |
| GO:0006401 | 2.61% | RNA catabolic process |
| GO:0033344 | 2.61% | cholesterol efflux |
| GO:0050873 | 2.61% | brown fat cell differentiation |
| GO:0043122 | 2.61% | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:1901565 | 2.60% | organonitrogen compound catabolic process |
| GO:2001020 | 2.60% | regulation of response to DNA damage stimulus |
| GO:2000027 | 2.60% | regulation of animal organ morphogenesis |
| GO:0006935 | 2.59% | chemotaxis |
| GO:0023061 | 2.59% | signal release |
| GO:0048582 | 2.58% | positive regulation of post-embryonic development |
| GO:0051147 | 2.58% | regulation of muscle cell differentiation |
| GO:0051053 | 2.58% | negative regulation of DNA metabolic process |
| GO:0050807 | 2.58% | regulation of synapse organization |
| GO:0065005 | 2.58% | protein-lipid complex assembly |
| GO:1901861 | 2.57% | regulation of muscle tissue development |
| GO:0002262 | 2.57% | myeloid cell homeostasis |
| GO:0030308 | 2.56% | negative regulation of cell growth |
| GO:0002227 | 2.56% | innate immune response in mucosa |
| GO:0044271 | 2.55% | cellular nitrogen compound biosynthetic process |
| GO:2000378 | 2.55% | negative regulation of reactive oxygen species metabolic process |
| GO:0040017 | 2.55% | positive regulation of locomotion |
| GO:0019827 | 2.54% | stem cell population maintenance |
| GO:0043603 | 2.54% | cellular amide metabolic process |
| GO:0019217 | 2.54% | regulation of fatty acid metabolic process |
| GO:0045912 | 2.54% | negative regulation of carbohydrate metabolic process |
| GO:0044267 | 2.54% | cellular protein metabolic process |
| GO:0046700 | 2.54% | heterocycle catabolic process |
| GO:0051705 | 2.54% | multi-organism behavior |
| GO:0002573 | 2.53% | myeloid leukocyte differentiation |
| GO:0010594 | 2.53% | regulation of endothelial cell migration |
| GO:0098609 | 2.53% | cell-cell adhesion |
| GO:0045475 | 2.53% | locomotor rhythm |
| GO:0002673 | 2.53% | regulation of acute inflammatory response |
| GO:0019748 | 2.52% | secondary metabolic process |
| GO:1905332 | 2.52% | positive regulation of morphogenesis of an epithelium |
| GO:0030431 | 2.51% | sleep |
| GO:0001562 | 2.51% | response to protozoan |
| GO:0045995 | 2.51% | regulation of embryonic development |
| GO:0009057 | 2.50% | macromolecule catabolic process |
| GO:0048873 | 2.50% | homeostasis of number of cells within a tissue |
| GO:0045663 | 2.50% | positive regulation of myoblast differentiation |
| GO:0002763 | 2.50% | positive regulation of myeloid leukocyte differentiation |
| GO:0006936 | 2.50% | muscle contraction |
| GO:0043567 | 2.50% | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0002385 | 2.49% | mucosal immune response |
| GO:0071363 | 2.49% | cellular response to growth factor stimulus |
| GO:0002009 | 2.49% | morphogenesis of an epithelium |
| GO:0010939 | 2.49% | regulation of necrotic cell death |
| GO:0050801 | 2.49% | ion homeostasis |
| GO:2000147 | 2.48% | positive regulation of cell motility |
| GO:0032652 | 2.48% | regulation of interleukin-1 production |
| GO:0032418 | 2.48% | lysosome localization |
| GO:0072332 | 2.47% | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0006383 | 2.47% | transcription by RNA polymerase III |
| GO:0030183 | 2.47% | B cell differentiation |
| GO:0030888 | 2.47% | regulation of B cell proliferation |
| GO:0006720 | 2.47% | isoprenoid metabolic process |
| GO:0090199 | 2.46% | regulation of release of cytochrome c from mitochondria |
| GO:0009744 | 2.46% | response to sucrose |
| GO:0006099 | 2.45% | tricarboxylic acid cycle |
| GO:0097327 | 2.45% | response to antineoplastic agent |
| GO:1903578 | 2.45% | regulation of ATP metabolic process |
| GO:0030335 | 2.45% | positive regulation of cell migration |
| GO:0045670 | 2.45% | regulation of osteoclast differentiation |
| GO:0097306 | 2.45% | cellular response to alcohol |
| GO:0034660 | 2.44% | ncRNA metabolic process |
| GO:0071392 | 2.44% | cellular response to estradiol stimulus |
| GO:0001570 | 2.44% | vasculogenesis |
| GO:0048563 | 2.44% | post-embryonic animal organ morphogenesis |
| GO:0003018 | 2.44% | vascular process in circulatory system |
| GO:0045682 | 2.44% | regulation of epidermis development |
| GO:0050871 | 2.43% | positive regulation of B cell activation |
| GO:1903580 | 2.42% | positive regulation of ATP metabolic process |
| GO:0006140 | 2.42% | regulation of nucleotide metabolic process |
| GO:0048538 | 2.42% | thymus development |
| GO:0070925 | 2.42% | organelle assembly |
| GO:1900542 | 2.42% | regulation of purine nucleotide metabolic process |
| GO:0022402 | 2.42% | cell cycle process |
| GO:2001242 | 2.41% | regulation of intrinsic apoptotic signaling pathway |
| GO:1903707 | 2.41% | negative regulation of hemopoiesis |
| GO:0002831 | 2.41% | regulation of response to biotic stimulus |
| GO:0030301 | 2.41% | cholesterol transport |
| GO:1902106 | 2.41% | negative regulation of leukocyte differentiation |
| GO:0003254 | 2.41% | regulation of membrane depolarization |
| GO:0018130 | 2.41% | heterocycle biosynthetic process |
| GO:0050778 | 2.41% | positive regulation of immune response |
| GO:0050920 | 2.41% | regulation of chemotaxis |
| GO:1900120 | 2.41% | regulation of receptor binding |
| GO:0042304 | 2.40% | regulation of fatty acid biosynthetic process |
| GO:0071384 | 2.40% | cellular response to corticosteroid stimulus |
| GO:0071674 | 2.40% | mononuclear cell migration |
| GO:0000003 | 2.39% | reproduction |
| GO:0045165 | 2.39% | cell fate commitment |
| GO:0071705 | 2.39% | nitrogen compound transport |
| GO:0090257 | 2.38% | regulation of muscle system process |
| GO:0002861 | 2.38% | regulation of inflammatory response to antigenic stimulus |
| GO:0030330 | 2.37% | DNA damage response, signal transduction by p53 class mediator |
| GO:0010001 | 2.37% | glial cell differentiation |
| GO:0048754 | 2.37% | branching morphogenesis of an epithelial tube |
| GO:0051402 | 2.36% | neuron apoptotic process |
| GO:0007168 | 2.36% | receptor guanylyl cyclase signaling pathway |
| GO:0051216 | 2.36% | cartilage development |
| GO:0001649 | 2.36% | osteoblast differentiation |
| GO:0090398 | 2.36% | cellular senescence |
| GO:0016202 | 2.36% | regulation of striated muscle tissue development |
| GO:0022411 | 2.35% | cellular component disassembly |
| GO:0006259 | 2.35% | DNA metabolic process |
| GO:0008543 | 2.35% | fibroblast growth factor receptor signaling pathway |
| GO:2000106 | 2.35% | regulation of leukocyte apoptotic process |
| GO:0097485 | 2.34% | neuron projection guidance |
| GO:0097722 | 2.34% | sperm motility |
| GO:1990823 | 2.34% | response to leukemia inhibitory factor |
| GO:0071383 | 2.34% | cellular response to steroid hormone stimulus |
| GO:2000058 | 2.34% | regulation of ubiquitin-dependent protein catabolic process |
| GO:1902117 | 2.33% | positive regulation of organelle assembly |
| GO:0006518 | 2.33% | peptide metabolic process |
| GO:0035265 | 2.32% | organ growth |
| GO:0030101 | 2.32% | natural killer cell activation |
| GO:0050905 | 2.32% | neuromuscular process |
| GO:0034661 | 2.32% | ncRNA catabolic process |
| GO:1901653 | 2.32% | cellular response to peptide |
| GO:0051272 | 2.32% | positive regulation of cellular component movement |
| GO:0016192 | 2.31% | vesicle-mediated transport |
| GO:0010743 | 2.31% | regulation of macrophage derived foam cell differentiation |
| GO:0071241 | 2.31% | cellular response to inorganic substance |
| GO:0048562 | 2.31% | embryonic organ morphogenesis |
| GO:1903036 | 2.31% | positive regulation of response to wounding |
| GO:0002065 | 2.31% | columnar/cuboidal epithelial cell differentiation |
| GO:0060285 | 2.30% | cilium-dependent cell motility |
| GO:0098727 | 2.30% | maintenance of cell number |
| GO:2001244 | 2.30% | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0030857 | 2.30% | negative regulation of epithelial cell differentiation |
| GO:0003002 | 2.30% | regionalization |
| GO:0071385 | 2.30% | cellular response to glucocorticoid stimulus |
| GO:0045913 | 2.29% | positive regulation of carbohydrate metabolic process |
| GO:1905952 | 2.29% | regulation of lipid localization |
| GO:0007006 | 2.28% | mitochondrial membrane organization |
| GO:0035150 | 2.28% | regulation of tube size |
| GO:1905954 | 2.28% | positive regulation of lipid localization |
| GO:0042110 | 2.28% | T cell activation |
| GO:0032943 | 2.28% | mononuclear cell proliferation |
| GO:0060261 | 2.28% | positive regulation of transcription initiation from RNA polymerase II promoter |
| GO:0071548 | 2.28% | response to dexamethasone |
| GO:0046651 | 2.28% | lymphocyte proliferation |
| GO:0045600 | 2.27% | positive regulation of fat cell differentiation |
| GO:0048634 | 2.27% | regulation of muscle organ development |
| GO:0019932 | 2.26% | second-messenger-mediated signaling |
| GO:0008347 | 2.26% | glial cell migration |
| GO:0002437 | 2.26% | inflammatory response to antigenic stimulus |
| GO:0045742 | 2.26% | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0090303 | 2.26% | positive regulation of wound healing |
| GO:0042552 | 2.25% | myelination |
| GO:0007015 | 2.25% | actin filament organization |
| GO:0010770 | 2.25% | positive regulation of cell morphogenesis involved in differentiation |
| GO:0009712 | 2.25% | catechol-containing compound metabolic process |
| GO:0019438 | 2.25% | aromatic compound biosynthetic process |
| GO:0071320 | 2.24% | cellular response to cAMP |
| GO:0071774 | 2.24% | response to fibroblast growth factor |
| GO:0010830 | 2.24% | regulation of myotube differentiation |
| GO:0046148 | 2.24% | pigment biosynthetic process |
| GO:0002548 | 2.24% | monocyte chemotaxis |
| GO:0051640 | 2.23% | organelle localization |
| GO:0034285 | 2.23% | response to disaccharide |
| GO:0010721 | 2.23% | negative regulation of cell development |
| GO:0051262 | 2.23% | protein tetramerization |
| GO:1901186 | 2.22% | positive regulation of ERBB signaling pathway |
| GO:0051926 | 2.22% | negative regulation of calcium ion transport |
| GO:0007411 | 2.22% | axon guidance |
| GO:0010665 | 2.22% | regulation of cardiac muscle cell apoptotic process |
| GO:0000904 | 2.22% | cell morphogenesis involved in differentiation |
| GO:0097028 | 2.22% | dendritic cell differentiation |
| GO:0110110 | 2.21% | positive regulation of animal organ morphogenesis |
| GO:0042755 | 2.20% | eating behavior |
| GO:0051656 | 2.20% | establishment of organelle localization |
| GO:0010469 | 2.20% | regulation of signaling receptor activity |
| GO:1903725 | 2.20% | regulation of phospholipid metabolic process |
| GO:0008202 | 2.20% | steroid metabolic process |
| GO:0071559 | 2.20% | response to transforming growth factor beta |
| GO:0032006 | 2.19% | regulation of TOR signaling |
| GO:0045776 | 2.19% | negative regulation of blood pressure |
| GO:0006464 | 2.19% | cellular protein modification process |
| GO:0036211 | 2.19% | protein modification process |
| GO:1905330 | 2.19% | regulation of morphogenesis of an epithelium |
| GO:0006575 | 2.19% | cellular modified amino acid metabolic process |
| GO:0030317 | 2.19% | flagellated sperm motility |
| GO:0032731 | 2.18% | positive regulation of interleukin-1 beta production |
| GO:0032673 | 2.18% | regulation of interleukin-4 production |
| GO:0040019 | 2.18% | positive regulation of embryonic development |
| GO:0032147 | 2.18% | activation of protein kinase activity |
| GO:0031333 | 2.18% | negative regulation of protein complex assembly |
| GO:0042770 | 2.18% | signal transduction in response to DNA damage |
| GO:1905897 | 2.18% | regulation of response to endoplasmic reticulum stress |
| GO:0045936 | 2.17% | negative regulation of phosphate metabolic process |
| GO:0010662 | 2.17% | regulation of striated muscle cell apoptotic process |
| GO:0071902 | 2.17% | positive regulation of protein serine/threonine kinase activity |
| GO:0045745 | 2.17% | positive regulation of G protein-coupled receptor signaling pathway |
| GO:2001237 | 2.16% | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0042832 | 2.16% | defense response to protozoan |
| GO:0010563 | 2.16% | negative regulation of phosphorus metabolic process |
| GO:0060135 | 2.15% | maternal process involved in female pregnancy |
| GO:0007259 | 2.15% | receptor signaling pathway via JAK-STAT |
| GO:1901135 | 2.15% | carbohydrate derivative metabolic process |
| GO:0043412 | 2.15% | macromolecule modification |
| GO:0006956 | 2.15% | complement activation |
| GO:0043043 | 2.14% | peptide biosynthetic process |
| GO:0034645 | 2.14% | cellular macromolecule biosynthetic process |
| GO:0032868 | 2.14% | response to insulin |
| GO:0045662 | 2.14% | negative regulation of myoblast differentiation |
| GO:0002263 | 2.13% | cell activation involved in immune response |
| GO:0008366 | 2.13% | axon ensheathment |
| GO:0060179 | 2.13% | male mating behavior |
| GO:0007349 | 2.13% | cellularization |
| GO:1901655 | 2.13% | cellular response to ketone |
| GO:0006066 | 2.13% | alcohol metabolic process |
| GO:1902115 | 2.13% | regulation of organelle assembly |
| GO:0042133 | 2.13% | neurotransmitter metabolic process |
| GO:0009648 | 2.13% | photoperiodism |
| GO:0097696 | 2.12% | receptor signaling pathway via STAT |
| GO:0018193 | 2.12% | peptidyl-amino acid modification |
| GO:0071375 | 2.12% | cellular response to peptide hormone stimulus |
| GO:0030324 | 2.12% | lung development |
| GO:0042048 | 2.12% | olfactory behavior |
| GO:0006396 | 2.11% | RNA processing |
| GO:0046907 | 2.11% | intracellular transport |
| GO:0046486 | 2.11% | glycerolipid metabolic process |
| GO:0007010 | 2.11% | cytoskeleton organization |
| GO:0032535 | 2.11% | regulation of cellular component size |
| GO:0006584 | 2.11% | catecholamine metabolic process |
| GO:0061900 | 2.11% | glial cell activation |
| GO:0009651 | 2.11% | response to salt stress |
| GO:0032732 | 2.11% | positive regulation of interleukin-1 production |
| GO:0046902 | 2.10% | regulation of mitochondrial membrane permeability |
| GO:0002685 | 2.10% | regulation of leukocyte migration |
| GO:0090183 | 2.10% | regulation of kidney development |
| GO:0030522 | 2.10% | intracellular receptor signaling pathway |
| GO:0045444 | 2.10% | fat cell differentiation |
| GO:1902107 | 2.10% | positive regulation of leukocyte differentiation |
| GO:0050869 | 2.10% | negative regulation of B cell activation |
| GO:0001890 | 2.10% | placenta development |
| GO:0043269 | 2.09% | regulation of ion transport |
| GO:1901992 | 2.09% | positive regulation of mitotic cell cycle phase transition |
| GO:0010661 | 2.09% | positive regulation of muscle cell apoptotic process |
| GO:0035239 | 2.09% | tube morphogenesis |
| GO:0045648 | 2.09% | positive regulation of erythrocyte differentiation |
| GO:0006412 | 2.08% | translation |
| GO:0009060 | 2.08% | aerobic respiration |
| GO:0016050 | 2.08% | vesicle organization |
| GO:0051447 | 2.07% | negative regulation of meiotic cell cycle |
| GO:0008037 | 2.07% | cell recognition |
| GO:0060759 | 2.07% | regulation of response to cytokine stimulus |
| GO:0044550 | 2.07% | secondary metabolite biosynthetic process |
| GO:0097529 | 2.07% | myeloid leukocyte migration |
| GO:0007179 | 2.07% | transforming growth factor beta receptor signaling pathway |
| GO:0035296 | 2.07% | regulation of tube diameter |
| GO:1905523 | 2.06% | positive regulation of macrophage migration |
| GO:0030510 | 2.06% | regulation of BMP signaling pathway |
| GO:0035108 | 2.06% | limb morphogenesis |
| GO:0070670 | 2.06% | response to interleukin-4 |
| GO:0007548 | 2.06% | sex differentiation |
| GO:0006801 | 2.06% | superoxide metabolic process |
| GO:0045835 | 2.06% | negative regulation of meiotic nuclear division |
| GO:0030595 | 2.06% | leukocyte chemotaxis |
| GO:0001708 | 2.05% | cell fate specification |
| GO:0048662 | 2.05% | negative regulation of smooth muscle cell proliferation |
| GO:0021954 | 2.05% | central nervous system neuron development |
| GO:1901988 | 2.05% | negative regulation of cell cycle phase transition |
| GO:0006790 | 2.05% | sulfur compound metabolic process |
| GO:0001937 | 2.05% | negative regulation of endothelial cell proliferation |
| GO:0009059 | 2.05% | macromolecule biosynthetic process |
| GO:0002790 | 2.04% | peptide secretion |
| GO:0035107 | 2.04% | appendage morphogenesis |
| GO:0017015 | 2.04% | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0055081 | 2.04% | anion homeostasis |
| GO:0045576 | 2.04% | mast cell activation |
| GO:0015918 | 2.03% | sterol transport |
| GO:0008286 | 2.03% | insulin receptor signaling pathway |
| GO:0090184 | 2.02% | positive regulation of kidney development |
| GO:0030435 | 2.02% | sporulation resulting in formation of a cellular spore |
| GO:0008154 | 2.02% | actin polymerization or depolymerization |
| GO:0009886 | 2.02% | post-embryonic animal morphogenesis |
| GO:0007507 | 2.02% | heart development |
| GO:0007272 | 2.02% | ensheathment of neurons |
| GO:0042446 | 2.02% | hormone biosynthetic process |
| GO:0045638 | 2.02% | negative regulation of myeloid cell differentiation |
| GO:0097746 | 2.01% | regulation of blood vessel diameter |
| GO:0043154 | 2.01% | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0046885 | 2.01% | regulation of hormone biosynthetic process |
| GO:0032434 | 2.01% | regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:0110149 | 2.01% | regulation of biomineralization |
| GO:0010043 | 2.01% | response to zinc ion |
| GO:2001021 | 2.01% | negative regulation of response to DNA damage stimulus |
| GO:0071467 | 2.01% | cellular response to pH |
| GO:0030901 | 2.00% | midbrain development |
| GO:0046034 | 2.00% | ATP metabolic process |
| GO:1903050 | 2.00% | regulation of proteolysis involved in cellular protein catabolic process |
| GO:0030279 | 2.00% | negative regulation of ossification |
| GO:0006397 | 2.00% | mRNA processing |
| GO:0042326 | 2.00% | negative regulation of phosphorylation |
| GO:0051047 | 2.00% | positive regulation of secretion |
| GO:0048247 | 1.99% | lymphocyte chemotaxis |
| GO:0070167 | 1.99% | regulation of biomineral tissue development |
| GO:0030500 | 1.99% | regulation of bone mineralization |
| GO:0001755 | 1.99% | neural crest cell migration |
| GO:0010508 | 1.99% | positive regulation of autophagy |
| GO:0008380 | 1.99% | RNA splicing |
| GO:1903530 | 1.99% | regulation of secretion by cell |
| GO:0045580 | 1.99% | regulation of T cell differentiation |
| GO:0010837 | 1.99% | regulation of keratinocyte proliferation |
| GO:0007632 | 1.99% | visual behavior |
| GO:0048661 | 1.98% | positive regulation of smooth muscle cell proliferation |
| GO:0022602 | 1.98% | ovulation cycle process |
| GO:0042058 | 1.98% | regulation of epidermal growth factor receptor signaling pathway |
| GO:0030728 | 1.98% | ovulation |
| GO:1990928 | 1.97% | response to amino acid starvation |
| GO:0006631 | 1.97% | fatty acid metabolic process |
| GO:1903319 | 1.97% | positive regulation of protein maturation |
| GO:0006820 | 1.97% | anion transport |
| GO:0034976 | 1.97% | response to endoplasmic reticulum stress |
| GO:0002832 | 1.97% | negative regulation of response to biotic stimulus |
| GO:0034654 | 1.97% | nucleobase-containing compound biosynthetic process |
| GO:0033555 | 1.97% | multicellular organismal response to stress |
| GO:0006694 | 1.96% | steroid biosynthetic process |
| GO:0043903 | 1.96% | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0043604 | 1.96% | amide biosynthetic process |
| GO:0001776 | 1.96% | leukocyte homeostasis |
| GO:0006082 | 1.96% | organic acid metabolic process |
| GO:0050867 | 1.95% | positive regulation of cell activation |
| GO:1903313 | 1.94% | positive regulation of mRNA metabolic process |
| GO:0061062 | 1.94% | regulation of nematode larval development |
| GO:0009738 | 1.94% | abscisic acid-activated signaling pathway |
| GO:0009751 | 1.94% | response to salicylic acid |
| GO:1901184 | 1.94% | regulation of ERBB signaling pathway |
| GO:0002696 | 1.93% | positive regulation of leukocyte activation |
| GO:0045785 | 1.93% | positive regulation of cell adhesion |
| GO:0050922 | 1.93% | negative regulation of chemotaxis |
| GO:0031139 | 1.93% | positive regulation of conjugation with cellular fusion |
| GO:0050931 | 1.93% | pigment cell differentiation |
| GO:0007017 | 1.93% | microtubule-based process |
| GO:1901222 | 1.93% | regulation of NIK/NF-kappaB signaling |
| GO:0072073 | 1.93% | kidney epithelium development |
| GO:0035019 | 1.92% | somatic stem cell population maintenance |
| GO:0022408 | 1.92% | negative regulation of cell-cell adhesion |
| GO:0033044 | 1.92% | regulation of chromosome organization |
| GO:0072521 | 1.92% | purine-containing compound metabolic process |
| GO:0002833 | 1.92% | positive regulation of response to biotic stimulus |
| GO:0021782 | 1.92% | glial cell development |
| GO:0045604 | 1.92% | regulation of epidermal cell differentiation |
| GO:0001959 | 1.92% | regulation of cytokine-mediated signaling pathway |
| GO:0009644 | 1.92% | response to high light intensity |
| GO:0006261 | 1.91% | DNA-dependent DNA replication |
| GO:0045787 | 1.91% | positive regulation of cell cycle |
| GO:0055086 | 1.91% | nucleobase-containing small molecule metabolic process |
| GO:0032787 | 1.91% | monocarboxylic acid metabolic process |
| GO:1902041 | 1.91% | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032368 | 1.91% | regulation of lipid transport |
| GO:0120163 | 1.91% | negative regulation of cold-induced thermogenesis |
| GO:0010954 | 1.91% | positive regulation of protein processing |
| GO:0043436 | 1.91% | oxoacid metabolic process |
| GO:0071466 | 1.90% | cellular response to xenobiotic stimulus |
| GO:0006812 | 1.90% | cation transport |
| GO:0042632 | 1.90% | cholesterol homeostasis |
| GO:0071549 | 1.90% | cellular response to dexamethasone stimulus |
| GO:0010660 | 1.90% | regulation of muscle cell apoptotic process |
| GO:0002052 | 1.90% | positive regulation of neuroblast proliferation |
| GO:0051048 | 1.89% | negative regulation of secretion |
| GO:0045932 | 1.89% | negative regulation of muscle contraction |
| GO:0045185 | 1.89% | maintenance of protein location |
| GO:0045667 | 1.89% | regulation of osteoblast differentiation |
| GO:0043331 | 1.89% | response to dsRNA |
| GO:0043299 | 1.89% | leukocyte degranulation |
| GO:0008361 | 1.89% | regulation of cell size |
| GO:0002703 | 1.89% | regulation of leukocyte mediated immunity |
| GO:1900424 | 1.89% | regulation of defense response to bacterium |
| GO:0007530 | 1.88% | sex determination |
| GO:0009635 | 1.88% | response to herbicide |
| GO:0009723 | 1.88% | response to ethylene |
| GO:0090092 | 1.87% | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0060560 | 1.87% | developmental growth involved in morphogenesis |
| GO:0032369 | 1.87% | negative regulation of lipid transport |
| GO:0051235 | 1.87% | maintenance of location |
| GO:0008542 | 1.87% | visual learning |
| GO:1904035 | 1.87% | regulation of epithelial cell apoptotic process |
| GO:2001243 | 1.87% | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0050817 | 1.86% | coagulation |
| GO:0043457 | 1.86% | regulation of cellular respiration |
| GO:0070269 | 1.86% | pyroptosis |
| GO:0047484 | 1.86% | regulation of response to osmotic stress |
| GO:0042044 | 1.86% | fluid transport |
| GO:0035162 | 1.86% | embryonic hemopoiesis |
| GO:0016999 | 1.86% | antibiotic metabolic process |
| GO:0002366 | 1.86% | leukocyte activation involved in immune response |
| GO:0018105 | 1.86% | peptidyl-serine phosphorylation |
| GO:0030072 | 1.86% | peptide hormone secretion |
| GO:0018212 | 1.86% | peptidyl-tyrosine modification |
| GO:0034754 | 1.85% | cellular hormone metabolic process |
| GO:0009793 | 1.85% | embryo development ending in seed dormancy |
| GO:0052803 | 1.85% | imidazole-containing compound metabolic process |
| GO:0019637 | 1.85% | organophosphate metabolic process |
| GO:0045685 | 1.85% | regulation of glial cell differentiation |
| GO:0006805 | 1.85% | xenobiotic metabolic process |
| GO:0019752 | 1.85% | carboxylic acid metabolic process |
| GO:0055082 | 1.84% | cellular chemical homeostasis |
| GO:0098754 | 1.84% | detoxification |
| GO:0045981 | 1.84% | positive regulation of nucleotide metabolic process |
| GO:0000122 | 1.84% | negative regulation of transcription by RNA polymerase II |
| GO:1903844 | 1.84% | regulation of cellular response to transforming growth factor beta stimulus |
| GO:1990089 | 1.84% | response to nerve growth factor |
| GO:1990090 | 1.83% | cellular response to nerve growth factor stimulus |
| GO:0071560 | 1.83% | cellular response to transforming growth factor beta stimulus |
| GO:1903428 | 1.83% | positive regulation of reactive oxygen species biosynthetic process |
| GO:0045017 | 1.83% | glycerolipid biosynthetic process |
| GO:0031136 | 1.83% | positive regulation of conjugation |
| GO:0050808 | 1.83% | synapse organization |
| GO:0045616 | 1.83% | regulation of keratinocyte differentiation |
| GO:0043934 | 1.83% | sporulation |
| GO:1903046 | 1.83% | meiotic cell cycle process |
| GO:0051952 | 1.83% | regulation of amine transport |
| GO:0048240 | 1.82% | sperm capacitation |
| GO:0042476 | 1.82% | odontogenesis |
| GO:0003014 | 1.82% | renal system process |
| GO:0009798 | 1.81% | axis specification |
| GO:0002687 | 1.81% | positive regulation of leukocyte migration |
| GO:2000351 | 1.81% | regulation of endothelial cell apoptotic process |
| GO:0055065 | 1.81% | metal ion homeostasis |
| GO:0015748 | 1.80% | organophosphate ester transport |
| GO:0018108 | 1.80% | peptidyl-tyrosine phosphorylation |
| GO:0050909 | 1.80% | sensory perception of taste |
| GO:1902742 | 1.80% | apoptotic process involved in development |
| GO:1902230 | 1.80% | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:1902074 | 1.80% | response to salt |
| GO:1905809 | 1.80% | negative regulation of synapse organization |
| GO:0002690 | 1.79% | positive regulation of leukocyte chemotaxis |
| GO:1901989 | 1.79% | positive regulation of cell cycle phase transition |
| GO:0051445 | 1.79% | regulation of meiotic cell cycle |
| GO:0007635 | 1.79% | chemosensory behavior |
| GO:0050996 | 1.79% | positive regulation of lipid catabolic process |
| GO:0032880 | 1.78% | regulation of protein localization |
| GO:2001022 | 1.78% | positive regulation of response to DNA damage stimulus |
| GO:0002886 | 1.78% | regulation of myeloid leukocyte mediated immunity |
| GO:1990748 | 1.78% | cellular detoxification |
| GO:0002119 | 1.78% | nematode larval development |
| GO:1903727 | 1.78% | positive regulation of phospholipid metabolic process |
| GO:0007162 | 1.78% | negative regulation of cell adhesion |
| GO:0007064 | 1.78% | mitotic sister chromatid cohesion |
| GO:0044058 | 1.77% | regulation of digestive system process |
| GO:0010470 | 1.77% | regulation of gastrulation |
| GO:0072347 | 1.77% | response to anesthetic |
| GO:0009268 | 1.77% | response to pH |
| GO:0002260 | 1.77% | lymphocyte homeostasis |
| GO:0032386 | 1.77% | regulation of intracellular transport |
| GO:0051099 | 1.77% | positive regulation of binding |
| GO:0034405 | 1.77% | response to fluid shear stress |
| GO:0071248 | 1.77% | cellular response to metal ion |
| GO:0002688 | 1.77% | regulation of leukocyte chemotaxis |
| GO:0043029 | 1.77% | T cell homeostasis |
| GO:1904037 | 1.77% | positive regulation of epithelial cell apoptotic process |
| GO:0006110 | 1.76% | regulation of glycolytic process |
| GO:0032649 | 1.76% | regulation of interferon-gamma production |
| GO:0035094 | 1.76% | response to nicotine |
| GO:0071887 | 1.76% | leukocyte apoptotic process |
| GO:0090087 | 1.76% | regulation of peptide transport |
| GO:0051954 | 1.76% | positive regulation of amine transport |
| GO:0048048 | 1.76% | embryonic eye morphogenesis |
| GO:0006937 | 1.75% | regulation of muscle contraction |
| GO:0070664 | 1.75% | negative regulation of leukocyte proliferation |
| GO:1900544 | 1.75% | positive regulation of purine nucleotide metabolic process |
| GO:0022407 | 1.75% | regulation of cell-cell adhesion |
| GO:0006633 | 1.75% | fatty acid biosynthetic process |
| GO:0060326 | 1.75% | cell chemotaxis |
| GO:0003015 | 1.74% | heart process |
| GO:0045721 | 1.74% | negative regulation of gluconeogenesis |
| GO:2000179 | 1.74% | positive regulation of neural precursor cell proliferation |
| GO:0006353 | 1.74% | DNA-templated transcription, termination |
| GO:0061136 | 1.74% | regulation of proteasomal protein catabolic process |
| GO:0051249 | 1.74% | regulation of lymphocyte activation |
| GO:1900371 | 1.74% | regulation of purine nucleotide biosynthetic process |
| GO:0051150 | 1.74% | regulation of smooth muscle cell differentiation |
| GO:0001658 | 1.74% | branching involved in ureteric bud morphogenesis |
| GO:0050921 | 1.74% | positive regulation of chemotaxis |
| GO:0055092 | 1.74% | sterol homeostasis |
| GO:0098771 | 1.74% | inorganic ion homeostasis |
| GO:0034050 | 1.73% | host programmed cell death induced by symbiont |
| GO:1902807 | 1.73% | negative regulation of cell cycle G1/S phase transition |
| GO:0048525 | 1.73% | negative regulation of viral process |
| GO:0043550 | 1.73% | regulation of lipid kinase activity |
| GO:0097530 | 1.73% | granulocyte migration |
| GO:0046883 | 1.73% | regulation of hormone secretion |
| GO:0030041 | 1.73% | actin filament polymerization |
| GO:0090069 | 1.72% | regulation of ribosome biogenesis |
| GO:0050863 | 1.72% | regulation of T cell activation |
| GO:0016042 | 1.72% | lipid catabolic process |
| GO:0060260 | 1.72% | regulation of transcription initiation from RNA polymerase II promoter |
| GO:0051961 | 1.72% | negative regulation of nervous system development |
| GO:0034613 | 1.72% | cellular protein localization |
| GO:0072330 | 1.72% | monocarboxylic acid biosynthetic process |
| GO:0009117 | 1.72% | nucleotide metabolic process |
| GO:0051603 | 1.72% | proteolysis involved in cellular protein catabolic process |
| GO:0008156 | 1.72% | negative regulation of DNA replication |
| GO:0007205 | 1.72% | protein kinase C-activating G protein-coupled receptor signaling pathway |
| GO:0001539 | 1.72% | cilium or flagellum-dependent cell motility |
| GO:0060341 | 1.71% | regulation of cellular localization |
| GO:0002164 | 1.71% | larval development |
| GO:0045732 | 1.71% | positive regulation of protein catabolic process |
| GO:0035113 | 1.71% | embryonic appendage morphogenesis |
| GO:0006753 | 1.71% | nucleoside phosphate metabolic process |
| GO:0051703 | 1.70% | intraspecies interaction between organisms |
| GO:0032689 | 1.70% | negative regulation of interferon-gamma production |
| GO:0019646 | 1.70% | aerobic electron transport chain |
| GO:0007409 | 1.70% | axonogenesis |
| GO:0007292 | 1.70% | female gamete generation |
| GO:0046999 | 1.70% | regulation of conjugation |
| GO:1901796 | 1.70% | regulation of signal transduction by p53 class mediator |
| GO:0008104 | 1.70% | protein localization |
| GO:0090279 | 1.70% | regulation of calcium ion import |
| GO:0010631 | 1.70% | epithelial cell migration |
| GO:0006281 | 1.69% | DNA repair |
| GO:0033036 | 1.69% | macromolecule localization |
| GO:0006310 | 1.69% | DNA recombination |
| GO:1901216 | 1.69% | positive regulation of neuron death |
| GO:0031137 | 1.69% | regulation of conjugation with cellular fusion |
| GO:0070663 | 1.69% | regulation of leukocyte proliferation |
| GO:0050772 | 1.69% | positive regulation of axonogenesis |
| GO:0030705 | 1.69% | cytoskeleton-dependent intracellular transport |
| GO:0060415 | 1.69% | muscle tissue morphogenesis |
| GO:0030217 | 1.69% | T cell differentiation |
| GO:0003156 | 1.69% | regulation of animal organ formation |
| GO:0015711 | 1.69% | organic anion transport |
| GO:0042886 | 1.69% | amide transport |
| GO:0050821 | 1.69% | protein stabilization |
| GO:0070169 | 1.68% | positive regulation of biomineral tissue development |
| GO:0043525 | 1.68% | positive regulation of neuron apoptotic process |
| GO:0032370 | 1.68% | positive regulation of lipid transport |
| GO:0002253 | 1.68% | activation of immune response |
| GO:0033013 | 1.68% | tetrapyrrole metabolic process |
| GO:0071300 | 1.67% | cellular response to retinoic acid |
| GO:0007596 | 1.67% | blood coagulation |
| GO:0014013 | 1.67% | regulation of gliogenesis |
| GO:0070727 | 1.67% | cellular macromolecule localization |
| GO:1903798 | 1.67% | regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:0055080 | 1.67% | cation homeostasis |
| GO:0051153 | 1.67% | regulation of striated muscle cell differentiation |
| GO:0019236 | 1.67% | response to pheromone |
| GO:0001501 | 1.66% | skeletal system development |
| GO:0070570 | 1.66% | regulation of neuron projection regeneration |
| GO:0008582 | 1.66% | regulation of synaptic growth at neuromuscular junction |
| GO:0015833 | 1.66% | peptide transport |
| GO:0010799 | 1.66% | regulation of peptidyl-threonine phosphorylation |
| GO:0032922 | 1.66% | circadian regulation of gene expression |
| GO:0009734 | 1.66% | auxin-activated signaling pathway |
| GO:0090693 | 1.66% | plant organ senescence |
| GO:2000144 | 1.66% | positive regulation of DNA-templated transcription, initiation |
| GO:0032660 | 1.65% | regulation of interleukin-17 production |
| GO:1901890 | 1.65% | positive regulation of cell junction assembly |
| GO:0010498 | 1.65% | proteasomal protein catabolic process |
| GO:0007178 | 1.65% | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051149 | 1.65% | positive regulation of muscle cell differentiation |
| GO:0043551 | 1.65% | regulation of phosphatidylinositol 3-kinase activity |
| GO:0046621 | 1.65% | negative regulation of organ growth |
| GO:0002312 | 1.64% | B cell activation involved in immune response |
| GO:1903047 | 1.64% | mitotic cell cycle process |
| GO:0120039 | 1.64% | plasma membrane bounded cell projection morphogenesis |
| GO:0032543 | 1.64% | mitochondrial translation |
| GO:1903670 | 1.64% | regulation of sprouting angiogenesis |
| GO:2000279 | 1.63% | negative regulation of DNA biosynthetic process |
| GO:1905820 | 1.63% | positive regulation of chromosome separation |
| GO:0009259 | 1.63% | ribonucleotide metabolic process |
| GO:0032092 | 1.63% | positive regulation of protein binding |
| GO:0030111 | 1.63% | regulation of Wnt signaling pathway |
| GO:0007249 | 1.63% | I-kappaB kinase/NF-kappaB signaling |
| GO:0009787 | 1.62% | regulation of abscisic acid-activated signaling pathway |
| GO:0002275 | 1.62% | myeloid cell activation involved in immune response |
| GO:0043502 | 1.62% | regulation of muscle adaptation |
| GO:0002675 | 1.62% | positive regulation of acute inflammatory response |
| GO:0055072 | 1.62% | iron ion homeostasis |
| GO:0033120 | 1.62% | positive regulation of RNA splicing |
| GO:1903531 | 1.61% | negative regulation of secretion by cell |
| GO:0110151 | 1.61% | positive regulation of biomineralization |
| GO:0046697 | 1.61% | decidualization |
| GO:0048812 | 1.61% | neuron projection morphogenesis |
| GO:0050433 | 1.61% | regulation of catecholamine secretion |
| GO:0001960 | 1.61% | negative regulation of cytokine-mediated signaling pathway |
| GO:0071675 | 1.61% | regulation of mononuclear cell migration |
| GO:0003085 | 1.61% | negative regulation of systemic arterial blood pressure |
| GO:0033238 | 1.61% | regulation of cellular amine metabolic process |
| GO:0002269 | 1.61% | leukocyte activation involved in inflammatory response |
| GO:0006638 | 1.61% | neutral lipid metabolic process |
| GO:0060760 | 1.60% | positive regulation of response to cytokine stimulus |
| GO:0140013 | 1.60% | meiotic nuclear division |
| GO:1905710 | 1.60% | positive regulation of membrane permeability |
| GO:0045669 | 1.59% | positive regulation of osteoblast differentiation |
| GO:0045599 | 1.59% | negative regulation of fat cell differentiation |
| GO:0010150 | 1.59% | leaf senescence |
| GO:0007599 | 1.59% | hemostasis |
| GO:0030029 | 1.59% | actin filament-based process |
| GO:1905957 | 1.59% | regulation of cellular response to alcohol |
| GO:0043588 | 1.59% | skin development |
| GO:0060148 | 1.59% | positive regulation of posttranscriptional gene silencing |
| GO:0043542 | 1.59% | endothelial cell migration |
| GO:0042069 | 1.59% | regulation of catecholamine metabolic process |
| GO:0042771 | 1.59% | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0051321 | 1.58% | meiotic cell cycle |
| GO:0032350 | 1.58% | regulation of hormone metabolic process |
| GO:0006163 | 1.58% | purine nucleotide metabolic process |
| GO:0002931 | 1.58% | response to ischemia |
| GO:2000178 | 1.57% | negative regulation of neural precursor cell proliferation |
| GO:0050768 | 1.57% | negative regulation of neurogenesis |
| GO:0046470 | 1.57% | phosphatidylcholine metabolic process |
| GO:0051602 | 1.57% | response to electrical stimulus |
| GO:0009415 | 1.57% | response to water |
| GO:1903364 | 1.57% | positive regulation of cellular protein catabolic process |
| GO:1900078 | 1.57% | positive regulation of cellular response to insulin stimulus |
| GO:0048858 | 1.57% | cell projection morphogenesis |
| GO:0002360 | 1.56% | T cell lineage commitment |
| GO:0098869 | 1.56% | cellular oxidant detoxification |
| GO:0046330 | 1.56% | positive regulation of JNK cascade |
| GO:2000134 | 1.56% | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0009309 | 1.56% | amine biosynthetic process |
| GO:1902253 | 1.56% | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:1905879 | 1.56% | regulation of oogenesis |
| GO:0070417 | 1.56% | cellular response to cold |
| GO:0022617 | 1.56% | extracellular matrix disassembly |
| GO:1904019 | 1.56% | epithelial cell apoptotic process |
| GO:0014031 | 1.56% | mesenchymal cell development |
| GO:0045778 | 1.56% | positive regulation of ossification |
| GO:0070201 | 1.56% | regulation of establishment of protein localization |
| GO:0044283 | 1.56% | small molecule biosynthetic process |
| GO:0048831 | 1.56% | regulation of shoot system development |
| GO:0043278 | 1.55% | response to morphine |
| GO:2000107 | 1.55% | negative regulation of leukocyte apoptotic process |
| GO:0060070 | 1.55% | canonical Wnt signaling pathway |
| GO:1904705 | 1.55% | regulation of vascular smooth muscle cell proliferation |
| GO:0009737 | 1.55% | response to abscisic acid |
| GO:0019724 | 1.55% | B cell mediated immunity |
| GO:0006308 | 1.55% | DNA catabolic process |
| GO:0072676 | 1.55% | lymphocyte migration |
| GO:1901566 | 1.55% | organonitrogen compound biosynthetic process |
| GO:0001952 | 1.55% | regulation of cell-matrix adhesion |
| GO:0002762 | 1.55% | negative regulation of myeloid leukocyte differentiation |
| GO:0030437 | 1.55% | ascospore formation |
| GO:0022413 | 1.54% | reproductive process in single-celled organism |
| GO:0043935 | 1.54% | sexual sporulation resulting in formation of a cellular spore |
| GO:0014910 | 1.54% | regulation of smooth muscle cell migration |
| GO:0015893 | 1.54% | drug transport |
| GO:0098801 | 1.54% | regulation of renal system process |
| GO:0002082 | 1.54% | regulation of oxidative phosphorylation |
| GO:0030514 | 1.54% | negative regulation of BMP signaling pathway |
| GO:0032735 | 1.54% | positive regulation of interleukin-12 production |
| GO:0042475 | 1.54% | odontogenesis of dentin-containing tooth |
| GO:0030326 | 1.53% | embryonic limb morphogenesis |
| GO:0006949 | 1.53% | syncytium formation |
| GO:0007614 | 1.53% | short-term memory |
| GO:0031638 | 1.53% | zymogen activation |
| GO:0010827 | 1.53% | regulation of glucose transmembrane transport |
| GO:0051898 | 1.53% | negative regulation of protein kinase B signaling |
| GO:0043114 | 1.53% | regulation of vascular permeability |
| GO:0009150 | 1.53% | purine ribonucleotide metabolic process |
| GO:0045736 | 1.53% | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0016075 | 1.53% | rRNA catabolic process |
| GO:0006144 | 1.53% | purine nucleobase metabolic process |
| GO:0042401 | 1.53% | cellular biogenic amine biosynthetic process |
| GO:0043161 | 1.52% | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO:0042130 | 1.52% | negative regulation of T cell proliferation |
| GO:0003382 | 1.52% | epithelial cell morphogenesis |
| GO:0010769 | 1.52% | regulation of cell morphogenesis involved in differentiation |
| GO:0030808 | 1.52% | regulation of nucleotide biosynthetic process |
| GO:0042246 | 1.52% | tissue regeneration |
| GO:0014015 | 1.52% | positive regulation of gliogenesis |
| GO:0050672 | 1.52% | negative regulation of lymphocyte proliferation |
| GO:0001774 | 1.51% | microglial cell activation |
| GO:0060251 | 1.51% | regulation of glial cell proliferation |
| GO:2000024 | 1.51% | regulation of leaf development |
| GO:0001933 | 1.51% | negative regulation of protein phosphorylation |
| GO:0007018 | 1.51% | microtubule-based movement |
| GO:0032655 | 1.51% | regulation of interleukin-12 production |
| GO:0030048 | 1.51% | actin filament-based movement |
| GO:0090090 | 1.51% | negative regulation of canonical Wnt signaling pathway |
| GO:0043087 | 1.51% | regulation of GTPase activity |
| GO:0043536 | 1.51% | positive regulation of blood vessel endothelial cell migration |
| GO:0009867 | 1.51% | jasmonic acid mediated signaling pathway |
| GO:0043489 | 1.51% | RNA stabilization |
| GO:0090322 | 1.51% | regulation of superoxide metabolic process |
| GO:0071402 | 1.51% | cellular response to lipoprotein particle stimulus |
| GO:0006260 | 1.50% | DNA replication |
| GO:0050892 | 1.50% | intestinal absorption |
| GO:0042026 | 1.50% | protein refolding |
| GO:1901419 | 1.50% | regulation of response to alcohol |
| GO:0050918 | 1.50% | positive chemotaxis |
| GO:0002791 | 1.50% | regulation of peptide secretion |
| GO:0040034 | 1.50% | regulation of development, heterochronic |
| GO:0030163 | 1.50% | protein catabolic process |
| GO:0061919 | 1.50% | process utilizing autophagic mechanism |
| GO:0007264 | 1.50% | small GTPase mediated signal transduction |
| GO:0006399 | 1.50% | tRNA metabolic process |
| GO:0043406 | 1.50% | positive regulation of MAP kinase activity |
| GO:1904396 | 1.50% | regulation of neuromuscular junction development |
| GO:0048705 | 1.50% | skeletal system morphogenesis |
| GO:0016036 | 1.50% | cellular response to phosphate starvation |
| GO:0032872 | 1.50% | regulation of stress-activated MAPK cascade |
| GO:0016032 | 1.49% | viral process |
| GO:0007193 | 1.49% | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0090025 | 1.49% | regulation of monocyte chemotaxis |
| GO:0002698 | 1.49% | negative regulation of immune effector process |
| GO:0045824 | 1.49% | negative regulation of innate immune response |
| GO:0002712 | 1.49% | regulation of B cell mediated immunity |
| GO:0033003 | 1.48% | regulation of mast cell activation |
| GO:0019934 | 1.48% | cGMP-mediated signaling |
| GO:0010171 | 1.48% | body morphogenesis |
| GO:0046320 | 1.48% | regulation of fatty acid oxidation |
| GO:0007616 | 1.48% | long-term memory |
| GO:0071731 | 1.48% | response to nitric oxide |
| GO:0048679 | 1.48% | response to isoquinoline alkaloid |
| GO:0014072 | 1.48% | regulation of axon regeneration |
| GO:0042737 | 1.48% | drug catabolic process |
| GO:0044062 | 1.48% | regulation of excretion |
| GO:0016072 | 1.48% | rRNA metabolic process |
| GO:0045428 | 1.48% | regulation of nitric oxide biosynthetic process |
| GO:0051984 | 1.48% | positive regulation of chromosome segregation |
| GO:0002686 | 1.48% | negative regulation of leukocyte migration |
| GO:1902229 | 1.48% | regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0009626 | 1.48% | plant-type hypersensitive response |
| GO:0001773 | 1.47% | myeloid dendritic cell activation |
| GO:0042692 | 1.47% | muscle cell differentiation |
| GO:0006639 | 1.47% | acylglycerol metabolic process |
| GO:0055010 | 1.47% | ventricular cardiac muscle tissue morphogenesis |
| GO:0031016 | 1.47% | pancreas development |
| GO:0097066 | 1.47% | response to thyroid hormone |
| GO:0006123 | 1.47% | mitochondrial electron transport, cytochrome c to oxygen |
| GO:0048536 | 1.47% | spleen development |
| GO:0003007 | 1.47% | heart morphogenesis |
| GO:0017157 | 1.46% | regulation of exocytosis |
| GO:0007140 | 1.46% | male meiotic nuclear division |
| GO:0060142 | 1.46% | regulation of syncytium formation by plasma membrane fusion |
| GO:0046626 | 1.46% | regulation of insulin receptor signaling pathway |
| GO:2001025 | 1.46% | positive regulation of response to drug |
| GO:0032945 | 1.46% | negative regulation of mononuclear cell proliferation |
| GO:0046068 | 1.46% | cGMP metabolic process |
| GO:0051101 | 1.46% | regulation of DNA binding |
| GO:0070373 | 1.46% | negative regulation of ERK1 and ERK2 cascade |
| GO:0048839 | 1.46% | inner ear development |
| GO:0060390 | 1.46% | regulation of SMAD protein signal transduction |
| GO:1900182 | 1.46% | positive regulation of protein localization to nucleus |
| GO:1905953 | 1.46% | negative regulation of lipid localization |
| GO:1901136 | 1.46% | carbohydrate derivative catabolic process |
| GO:0010042 | 1.46% | response to manganese ion |
| GO:0006972 | 1.46% | hyperosmotic response |
| GO:0043516 | 1.46% | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0032007 | 1.46% | negative regulation of TOR signaling |
| GO:0010831 | 1.45% | positive regulation of myotube differentiation |
| GO:0070302 | 1.45% | regulation of stress-activated protein kinase signaling cascade |
| GO:0042116 | 1.45% | macrophage activation |
| GO:0071353 | 1.45% | cellular response to interleukin-4 |
| GO:0001764 | 1.45% | neuron migration |
| GO:1903573 | 1.45% | negative regulation of response to endoplasmic reticulum stress |
| GO:0006662 | 1.44% | glycerol ether metabolic process |
| GO:0051148 | 1.44% | negative regulation of muscle cell differentiation |
| GO:1901570 | 1.44% | fatty acid derivative biosynthetic process |
| GO:0050886 | 1.44% | endocrine process |
| GO:0043279 | 1.44% | response to alkaloid |
| GO:0071276 | 1.44% | cellular response to cadmium ion |
| GO:0019693 | 1.44% | ribose phosphate metabolic process |
| GO:0035136 | 1.44% | forelimb morphogenesis |
| GO:0060761 | 1.44% | negative regulation of response to cytokine stimulus |
| GO:0032784 | 1.44% | regulation of DNA-templated transcription, elongation |
| GO:0035188 | 1.44% | hatching |
| GO:0048544 | 1.43% | recognition of pollen |
| GO:0055008 | 1.43% | cardiac muscle tissue morphogenesis |
| GO:0000278 | 1.43% | mitotic cell cycle |
| GO:0080154 | 1.43% | regulation of fertilization |
| GO:0090101 | 1.43% | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0045687 | 1.43% | positive regulation of glial cell differentiation |
| GO:0045793 | 1.43% | positive regulation of cell size |
| GO:0009414 | 1.43% | response to water deprivation |
| GO:0048259 | 1.42% | regulation of receptor-mediated endocytosis |
| GO:0045088 | 1.42% | regulation of innate immune response |
| GO:1903052 | 1.42% | positive regulation of proteolysis involved in cellular protein catabolic process |
| GO:0051188 | 1.42% | cofactor biosynthetic process |
| GO:0022618 | 1.42% | ribonucleoprotein complex assembly |
| GO:0070085 | 1.42% | glycosylation |
| GO:0045620 | 1.42% | negative regulation of lymphocyte differentiation |
| GO:0030178 | 1.42% | negative regulation of Wnt signaling pathway |
| GO:1901797 | 1.42% | negative regulation of signal transduction by p53 class mediator |
| GO:0030890 | 1.42% | positive regulation of B cell proliferation |
| GO:0043409 | 1.42% | negative regulation of MAPK cascade |
| GO:0009753 | 1.42% | response to jasmonic acid |
| GO:0051187 | 1.42% | cofactor catabolic process |
| GO:0046622 | 1.42% | positive regulation of organ growth |
| GO:2001222 | 1.41% | regulation of neuron migration |
| GO:0051250 | 1.41% | negative regulation of lymphocyte activation |
| GO:1904706 | 1.41% | negative regulation of vascular smooth muscle cell proliferation |
| GO:0051223 | 1.41% | regulation of protein transport |
| GO:0031647 | 1.41% | regulation of protein stability |
| GO:0043500 | 1.41% | muscle adaptation |
| GO:0031400 | 1.41% | negative regulation of protein modification process |
| GO:0060359 | 1.41% | response to ammonium ion |
| GO:0006379 | 1.41% | mRNA cleavage |
| GO:0009642 | 1.41% | response to light intensity |
| GO:0070665 | 1.41% | positive regulation of leukocyte proliferation |
| GO:0050685 | 1.41% | positive regulation of mRNA processing |
| GO:1903312 | 1.41% | negative regulation of mRNA metabolic process |
| GO:0006914 | 1.40% | autophagy |
| GO:0007229 | 1.40% | integrin-mediated signaling pathway |
| GO:0042303 | 1.40% | molting cycle |
| GO:0006650 | 1.40% | glycerophospholipid metabolic process |
| GO:0010676 | 1.40% | positive regulation of cellular carbohydrate metabolic process |
| GO:0046328 | 1.40% | regulation of JNK cascade |
| GO:0014850 | 1.40% | response to muscle activity |
| GO:0001961 | 1.40% | positive regulation of cytokine-mediated signaling pathway |
| GO:1903320 | 1.40% | regulation of protein modification by small protein conjugation or removal |
| GO:0048864 | 1.40% | stem cell development |
| GO:0006111 | 1.40% | regulation of gluconeogenesis |
| GO:0042572 | 1.40% | retinol metabolic process |
| GO:0032786 | 1.39% | positive regulation of DNA-templated transcription, elongation |
| GO:0099177 | 1.39% | regulation of trans-synaptic signaling |
| GO:0045184 | 1.39% | establishment of protein localization |
| GO:0043562 | 1.39% | cellular response to nitrogen levels |
| GO:0034394 | 1.39% | protein localization to cell surface |
| GO:0043255 | 1.39% | regulation of carbohydrate biosynthetic process |
| GO:0005975 | 1.39% | carbohydrate metabolic process |
| GO:2000249 | 1.39% | regulation of actin cytoskeleton reorganization |
| GO:0031341 | 1.39% | regulation of cell killing |
| GO:0010959 | 1.39% | regulation of metal ion transport |
| GO:0010883 | 1.39% | regulation of lipid storage |
| GO:1903409 | 1.38% | reactive oxygen species biosynthetic process |
| GO:0072163 | 1.38% | mesonephric epithelium development |
| GO:0045939 | 1.38% | negative regulation of steroid metabolic process |
| GO:0006511 | 1.38% | ubiquitin-dependent protein catabolic process |
| GO:0034391 | 1.38% | regulation of smooth muscle cell apoptotic process |
| GO:0007187 | 1.38% | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0032069 | 1.38% | regulation of nuclease activity |
| GO:0007619 | 1.38% | courtship behavior |
| GO:0015031 | 1.38% | protein transport |
| GO:1902893 | 1.38% | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:1901991 | 1.38% | negative regulation of mitotic cell cycle phase transition |
| GO:0051276 | 1.38% | chromosome organization |
| GO:0009988 | 1.37% | cell-cell recognition |
| GO:0050684 | 1.37% | regulation of mRNA processing |
| GO:1990266 | 1.37% | neutrophil migration |
| GO:0006268 | 1.37% | DNA unwinding involved in DNA replication |
| GO:0043473 | 1.37% | pigmentation |
| GO:0032968 | 1.37% | positive regulation of transcription elongation from RNA polymerase II promoter |
| GO:1900087 | 1.37% | positive regulation of G1/S transition of mitotic cell cycle |
| GO:1905818 | 1.37% | regulation of chromosome separation |
| GO:0030001 | 1.37% | metal ion transport |
| GO:0022008 | 1.37% | neurogenesis |
| GO:0006282 | 1.37% | regulation of DNA repair |
| GO:0040020 | 1.37% | regulation of meiotic nuclear division |
| GO:0048255 | 1.36% | mRNA stabilization |
| GO:0090342 | 1.36% | regulation of cell aging |
| GO:0051783 | 1.36% | regulation of nuclear division |
| GO:0044070 | 1.36% | regulation of anion transport |
| GO:0030168 | 1.36% | platelet activation |
| GO:0061982 | 1.36% | meiosis I cell cycle process |
| GO:0014911 | 1.36% | positive regulation of smooth muscle cell migration |
| GO:0051654 | 1.36% | establishment of mitochondrion localization |
| GO:0016053 | 1.36% | organic acid biosynthetic process |
| GO:0006458 | 1.36% | 'de novo' protein folding |
| GO:1902373 | 1.36% | negative regulation of mRNA catabolic process |
| GO:0010623 | 1.35% | programmed cell death involved in cell development |
| GO:0048477 | 1.35% | oogenesis |
| GO:0045723 | 1.35% | positive regulation of fatty acid biosynthetic process |
| GO:2000637 | 1.35% | positive regulation of gene silencing by miRNA |
| GO:0010823 | 1.35% | negative regulation of mitochondrion organization |
| GO:0002889 | 1.35% | regulation of immunoglobulin mediated immune response |
| GO:0032365 | 1.35% | intracellular lipid transport |
| GO:0009952 | 1.35% | anterior/posterior pattern specification |
| GO:0010970 | 1.35% | transport along microtubule |
| GO:0098630 | 1.34% | aggregation of unicellular organisms |
| GO:0071103 | 1.34% | DNA conformation change |
| GO:1901678 | 1.34% | iron coordination entity transport |
| GO:0048261 | 1.34% | negative regulation of receptor-mediated endocytosis |
| GO:0048581 | 1.34% | negative regulation of post-embryonic development |
| GO:1904030 | 1.34% | negative regulation of cyclin-dependent protein kinase activity |
| GO:0009953 | 1.34% | dorsal/ventral pattern formation |
| GO:0002718 | 1.34% | regulation of cytokine production involved in immune response |
| GO:0031343 | 1.34% | positive regulation of cell killing |
| GO:0008585 | 1.34% | female gonad development |
| GO:0045668 | 1.34% | negative regulation of osteoblast differentiation |
| GO:0072678 | 1.33% | T cell migration |
| GO:0048147 | 1.33% | negative regulation of fibroblast proliferation |
| GO:0009880 | 1.33% | embryonic pattern specification |
| GO:0001656 | 1.33% | metanephros development |
| GO:0030513 | 1.33% | positive regulation of BMP signaling pathway |
| GO:0048704 | 1.33% | embryonic skeletal system morphogenesis |
| GO:0048709 | 1.33% | oligodendrocyte differentiation |
| GO:1903008 | 1.33% | organelle disassembly |
| GO:0090068 | 1.33% | positive regulation of cell cycle process |
| GO:0009639 | 1.33% | response to red or far red light |
| GO:0097366 | 1.33% | response to bronchodilator |
| GO:0050792 | 1.32% | regulation of viral process |
| GO:0031570 | 1.32% | DNA integrity checkpoint |
| GO:0051348 | 1.32% | negative regulation of transferase activity |
| GO:0002705 | 1.32% | positive regulation of leukocyte mediated immunity |
| GO:0072595 | 1.32% | maintenance of protein localization in organelle |
| GO:1903322 | 1.32% | positive regulation of protein modification by small protein conjugation or removal |
| GO:0042157 | 1.32% | lipoprotein metabolic process |
| GO:0140253 | 1.32% | cell-cell fusion |
| GO:0034110 | 1.32% | regulation of homotypic cell-cell adhesion |
| GO:0046474 | 1.32% | glycerophospholipid biosynthetic process |
| GO:0001662 | 1.32% | behavioral fear response |
| GO:0070228 | 1.32% | regulation of lymphocyte apoptotic process |
| GO:1903305 | 1.32% | regulation of regulated secretory pathway |
| GO:0002793 | 1.32% | positive regulation of peptide secretion |
| GO:0000375 | 1.32% | RNA splicing, via transesterification reactions |
| GO:0032869 | 1.32% | cellular response to insulin stimulus |
| GO:0030100 | 1.32% | regulation of endocytosis |
| GO:0006352 | 1.31% | DNA-templated transcription, initiation |
| GO:0001944 | 1.31% | vasculature development |
| GO:0090218 | 1.31% | positive regulation of lipid kinase activity |
| GO:0071869 | 1.31% | response to catecholamine |
| GO:0032148 | 1.31% | activation of protein kinase B activity |
| GO:1902808 | 1.31% | positive regulation of cell cycle G1/S phase transition |
| GO:0061014 | 1.31% | positive regulation of mRNA catabolic process |
| GO:0006940 | 1.31% | regulation of smooth muscle contraction |
| GO:0010894 | 1.30% | negative regulation of steroid biosynthetic process |
| GO:0050766 | 1.30% | positive regulation of phagocytosis |
| GO:0006995 | 1.30% | cellular response to nitrogen starvation |
| GO:0043552 | 1.30% | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0047497 | 1.30% | mitochondrion transport along microtubule |
| GO:0045830 | 1.30% | positive regulation of isotype switching |
| GO:0009733 | 1.30% | response to auxin |
| GO:0045746 | 1.30% | negative regulation of Notch signaling pathway |
| GO:0045191 | 1.30% | regulation of isotype switching |
| GO:0002888 | 1.30% | positive regulation of myeloid leukocyte mediated immunity |
| GO:0060828 | 1.29% | regulation of canonical Wnt signaling pathway |
| GO:0010803 | 1.29% | regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0060706 | 1.29% | cell differentiation involved in embryonic placenta development |
| GO:1905939 | 1.29% | regulation of gonad development |
| GO:0046394 | 1.29% | carboxylic acid biosynthetic process |
| GO:1902991 | 1.29% | regulation of amyloid precursor protein catabolic process |
| GO:0006022 | 1.29% | aminoglycan metabolic process |
| GO:0071622 | 1.29% | regulation of granulocyte chemotaxis |
| GO:0000737 | 1.29% | DNA catabolic process, endonucleolytic |
| GO:0045686 | 1.29% | negative regulation of glial cell differentiation |
| GO:0062033 | 1.29% | positive regulation of mitotic sister chromatid segregation |
| GO:0031505 | 1.28% | fungal-type cell wall organization |
| GO:0051924 | 1.28% | regulation of calcium ion transport |
| GO:0090598 | 1.28% | male anatomical structure morphogenesis |
| GO:0051084 | 1.28% | 'de novo' posttranslational protein folding |
| GO:2001252 | 1.28% | positive regulation of chromosome organization |
| GO:0000725 | 1.28% | recombinational repair |
| GO:0048771 | 1.28% | tissue remodeling |
| GO:0032008 | 1.28% | positive regulation of TOR signaling |
| GO:0070059 | 1.28% | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0043547 | 1.28% | positive regulation of GTPase activity |
| GO:0046456 | 1.28% | icosanoid biosynthetic process |
| GO:0019226 | 1.28% | transmission of nerve impulse |
| GO:1903532 | 1.28% | positive regulation of secretion by cell |
| GO:0048663 | 1.28% | neuron fate commitment |
| GO:0002429 | 1.27% | immune response-activating cell surface receptor signaling pathway |
| GO:0010575 | 1.27% | positive regulation of vascular endothelial growth factor production |
| GO:0014075 | 1.27% | response to amine |
| GO:0045429 | 1.27% | positive regulation of nitric oxide biosynthetic process |
| GO:0060191 | 1.27% | regulation of lipase activity |
| GO:0033280 | 1.27% | response to vitamin D |
| GO:0010259 | 1.27% | multicellular organism aging |
| GO:0060429 | 1.27% | epithelium development |
| GO:1901623 | 1.27% | regulation of lymphocyte chemotaxis |
| GO:1903307 | 1.27% | positive regulation of regulated secretory pathway |
| GO:0031152 | 1.27% | aggregation involved in sorocarp development |
| GO:0072594 | 1.27% | establishment of protein localization to organelle |
| GO:0061061 | 1.27% | muscle structure development |
| GO:0031396 | 1.27% | regulation of protein ubiquitination |
| GO:0021675 | 1.27% | nerve development |
| GO:0035148 | 1.27% | tube formation |
| GO:1904036 | 1.27% | negative regulation of epithelial cell apoptotic process |
| GO:1902895 | 1.27% | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0033005 | 1.27% | positive regulation of mast cell activation |
| GO:0016114 | 1.27% | terpenoid biosynthetic process |
| GO:0001935 | 1.26% | endothelial cell proliferation |
| GO:0006968 | 1.26% | cellular defense response |
| GO:0023014 | 1.26% | signal transduction by protein phosphorylation |
| GO:0042659 | 1.26% | regulation of cell fate specification |
| GO:0046887 | 1.26% | positive regulation of hormone secretion |
| GO:0000075 | 1.26% | cell cycle checkpoint |
| GO:0046632 | 1.26% | alpha-beta T cell differentiation |
| GO:0060999 | 1.26% | positive regulation of dendritic spine development |
| GO:0000077 | 1.26% | DNA damage checkpoint |
| GO:0033673 | 1.26% | negative regulation of kinase activity |
| GO:0071692 | 1.26% | protein localization to extracellular region |
| GO:0098586 | 1.26% | cellular response to virus |
| GO:0071555 | 1.26% | cell wall organization |
| GO:0071554 | 1.26% | cell wall organization or biogenesis |
| GO:0010667 | 1.25% | negative regulation of cardiac muscle cell apoptotic process |
| GO:0014032 | 1.25% | neural crest cell development |
| GO:0006836 | 1.25% | neurotransmitter transport |
| GO:0045621 | 1.25% | positive regulation of lymphocyte differentiation |
| GO:0019430 | 1.25% | removal of superoxide radicals |
| GO:0032928 | 1.25% | regulation of superoxide anion generation |
| GO:1904029 | 1.25% | regulation of cyclin-dependent protein kinase activity |
| GO:0007188 | 1.25% | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0009637 | 1.25% | response to blue light |
| GO:0043010 | 1.25% | camera-type eye development |
| GO:0032720 | 1.25% | negative regulation of tumor necrosis factor production |
| GO:0001835 | 1.25% | blastocyst hatching |
| GO:0006040 | 1.25% | amino sugar metabolic process |
| GO:0009190 | 1.25% | cyclic nucleotide biosynthetic process |
| GO:0051155 | 1.25% | positive regulation of striated muscle cell differentiation |
| GO:0034114 | 1.25% | regulation of heterotypic cell-cell adhesion |
| GO:0010332 | 1.25% | response to gamma radiation |
| GO:0061448 | 1.25% | connective tissue development |
| GO:1901568 | 1.25% | fatty acid derivative metabolic process |
| GO:0071826 | 1.25% | ribonucleoprotein complex subunit organization |
| GO:0050764 | 1.25% | regulation of phagocytosis |
| GO:0045671 | 1.24% | negative regulation of osteoclast differentiation |
| GO:1904707 | 1.24% | positive regulation of vascular smooth muscle cell proliferation |
| GO:0018904 | 1.24% | ether metabolic process |
| GO:0015914 | 1.24% | phospholipid transport |
| GO:0010288 | 1.24% | response to lead ion |
| GO:0051493 | 1.24% | regulation of cytoskeleton organization |
| GO:0006547 | 1.24% | histidine metabolic process |
| GO:0034587 | 1.24% | piRNA metabolic process |
| GO:1903556 | 1.24% | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0099402 | 1.24% | plant organ development |
| GO:0055094 | 1.24% | response to lipoprotein particle |
| GO:0035112 | 1.24% | genitalia morphogenesis |
| GO:0000724 | 1.24% | double-strand break repair via homologous recombination |
| GO:1903793 | 1.23% | positive regulation of anion transport |
| GO:0016125 | 1.23% | sterol metabolic process |
| GO:2000401 | 1.23% | regulation of lymphocyte migration |
| GO:0031288 | 1.23% | sorocarp morphogenesis |
| GO:0008203 | 1.23% | cholesterol metabolic process |
| GO:0060147 | 1.23% | regulation of posttranscriptional gene silencing |
| GO:0033209 | 1.23% | tumor necrosis factor-mediated signaling pathway |
| GO:0019985 | 1.23% | translesion synthesis |
| GO:0033688 | 1.23% | regulation of osteoblast proliferation |
| GO:1900140 | 1.23% | regulation of seedling development |
| GO:0055076 | 1.23% | transition metal ion homeostasis |
| GO:0051769 | 1.23% | regulation of nitric-oxide synthase biosynthetic process |
| GO:0050804 | 1.22% | modulation of chemical synaptic transmission |
| GO:0035592 | 1.22% | establishment of protein localization to extracellular region |
| GO:0048592 | 1.22% | eye morphogenesis |
| GO:0000377 | 1.22% | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| GO:0048026 | 1.22% | positive regulation of mRNA splicing, via spliceosome |
| GO:0060612 | 1.22% | adipose tissue development |
| GO:0006942 | 1.22% | regulation of striated muscle contraction |
| GO:0060964 | 1.22% | regulation of gene silencing by miRNA |
| GO:0010633 | 1.22% | negative regulation of epithelial cell migration |
| GO:0014888 | 1.22% | striated muscle adaptation |
| GO:0044282 | 1.22% | small molecule catabolic process |
| GO:0033365 | 1.22% | protein localization to organelle |
| GO:0051339 | 1.22% | regulation of lyase activity |
| GO:0030501 | 1.22% | positive regulation of bone mineralization |
| GO:0009948 | 1.22% | anterior/posterior axis specification |
| GO:0019369 | 1.22% | arachidonic acid metabolic process |
| GO:2000059 | 1.22% | negative regulation of ubiquitin-dependent protein catabolic process |
| GO:0034762 | 1.22% | regulation of transmembrane transport |
| GO:0031145 | 1.21% | anaphase-promoting complex-dependent catabolic process |
| GO:0044344 | 1.21% | cellular response to fibroblast growth factor stimulus |
| GO:0052652 | 1.21% | cyclic purine nucleotide metabolic process |
| GO:1900101 | 1.21% | regulation of endoplasmic reticulum unfolded protein response |
| GO:0043433 | 1.21% | negative regulation of DNA-binding transcription factor activity |
| GO:1901617 | 1.21% | organic hydroxy compound biosynthetic process |
| GO:0051495 | 1.21% | positive regulation of cytoskeleton organization |
| GO:0070168 | 1.21% | negative regulation of biomineral tissue development |
| GO:1900151 | 1.21% | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:0042743 | 1.21% | hydrogen peroxide metabolic process |
| GO:0035115 | 1.20% | embryonic forelimb morphogenesis |
| GO:0015908 | 1.20% | fatty acid transport |
| GO:0000018 | 1.20% | regulation of DNA recombination |
| GO:2000736 | 1.20% | regulation of stem cell differentiation |
| GO:0014059 | 1.20% | regulation of dopamine secretion |
| GO:0034643 | 1.20% | establishment of mitochondrion localization, microtubule-mediated |
| GO:0006826 | 1.20% | iron ion transport |
| GO:0015849 | 1.20% | organic acid transport |
| GO:0010907 | 1.20% | positive regulation of glucose metabolic process |
| GO:0009306 | 1.20% | protein secretion |
| GO:0044770 | 1.20% | cell cycle phase transition |
| GO:0070873 | 1.20% | regulation of glycogen metabolic process |
| GO:0034243 | 1.20% | regulation of transcription elongation from RNA polymerase II promoter |
| GO:0071867 | 1.20% | response to monoamine |
| GO:0002090 | 1.20% | regulation of receptor internalization |
| GO:0060998 | 1.20% | regulation of dendritic spine development |
| GO:0071468 | 1.19% | cellular response to acidic pH |
| GO:0014014 | 1.19% | negative regulation of gliogenesis |
| GO:0120178 | 1.19% | steroid hormone biosynthetic process |
| GO:0007585 | 1.19% | respiratory gaseous exchange by respiratory system |
| GO:2000108 | 1.19% | positive regulation of leukocyte apoptotic process |
| GO:0048514 | 1.19% | blood vessel morphogenesis |
| GO:0010226 | 1.19% | response to lithium ion |
| GO:0051251 | 1.19% | positive regulation of lymphocyte activation |
| GO:0009260 | 1.19% | ribonucleotide biosynthetic process |
| GO:0055074 | 1.19% | calcium ion homeostasis |
| GO:0110150 | 1.19% | negative regulation of biomineralization |
| GO:0034105 | 1.19% | positive regulation of tissue remodeling |
| GO:0051651 | 1.19% | maintenance of location in cell |
| GO:0007127 | 1.19% | meiosis I |
| GO:0060966 | 1.19% | regulation of gene silencing by RNA |
| GO:0033045 | 1.19% | regulation of sister chromatid segregation |
| GO:0010389 | 1.19% | regulation of G2/M transition of mitotic cell cycle |
| GO:0000731 | 1.18% | DNA synthesis involved in DNA repair |
| GO:0051341 | 1.18% | regulation of oxidoreductase activity |
| GO:2000403 | 1.18% | positive regulation of lymphocyte migration |
| GO:0031398 | 1.18% | positive regulation of protein ubiquitination |
| GO:0070920 | 1.18% | regulation of production of small RNA involved in gene silencing by RNA |
| GO:0000165 | 1.18% | MAPK cascade |
| GO:0061515 | 1.18% | myeloid cell development |
| GO:0070206 | 1.18% | protein trimerization |
| GO:0010812 | 1.18% | negative regulation of cell-substrate adhesion |
| GO:0021766 | 1.18% | hippocampus development |
| GO:0070304 | 1.18% | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0030947 | 1.18% | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0009909 | 1.18% | regulation of flower development |
| GO:0071684 | 1.18% | organism emergence from protective structure |
| GO:1903363 | 1.18% | negative regulation of cellular protein catabolic process |
| GO:0033619 | 1.17% | membrane protein proteolysis |
| GO:0006641 | 1.17% | triglyceride metabolic process |
| GO:0032892 | 1.17% | positive regulation of organic acid transport |
| GO:0050927 | 1.17% | positive regulation of positive chemotaxis |
| GO:0010965 | 1.17% | regulation of mitotic sister chromatid separation |
| GO:0043300 | 1.17% | regulation of leukocyte degranulation |
| GO:0045229 | 1.17% | external encapsulating structure organization |
| GO:1902235 | 1.17% | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| GO:0032330 | 1.17% | regulation of chondrocyte differentiation |
| GO:0048024 | 1.17% | regulation of mRNA splicing, via spliceosome |
| GO:1903432 | 1.17% | regulation of TORC1 signaling |
| GO:0006958 | 1.17% | complement activation, classical pathway |
| GO:0046628 | 1.17% | positive regulation of insulin receptor signaling pathway |
| GO:0071480 | 1.17% | cellular response to gamma radiation |
| GO:0006636 | 1.17% | unsaturated fatty acid biosynthetic process |
| GO:2000060 | 1.17% | positive regulation of ubiquitin-dependent protein catabolic process |
| GO:0071470 | 1.17% | cellular response to osmotic stress |
| GO:0002768 | 1.17% | immune response-regulating cell surface receptor signaling pathway |
| GO:0006302 | 1.17% | double-strand break repair |
| GO:0032874 | 1.16% | positive regulation of stress-activated MAPK cascade |
| GO:1901522 | 1.16% | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:0061726 | 1.16% | mitochondrion disassembly |
| GO:0042634 | 1.16% | regulation of hair cycle |
| GO:0032944 | 1.16% | regulation of mononuclear cell proliferation |
| GO:1903900 | 1.16% | regulation of viral life cycle |
| GO:0014912 | 1.16% | negative regulation of smooth muscle cell migration |
| GO:0006941 | 1.16% | striated muscle contraction |
| GO:0090288 | 1.16% | negative regulation of cellular response to growth factor stimulus |
| GO:0003044 | 1.16% | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0009855 | 1.16% | determination of bilateral symmetry |
| GO:1902749 | 1.16% | regulation of cell cycle G2/M phase transition |
| GO:0051973 | 1.16% | positive regulation of telomerase activity |
| GO:0019935 | 1.16% | cyclic-nucleotide-mediated signaling |
| GO:0008360 | 1.16% | regulation of cell shape |
| GO:0048569 | 1.15% | post-embryonic animal organ development |
| GO:0051983 | 1.15% | regulation of chromosome segregation |
| GO:0048168 | 1.15% | regulation of neuronal synaptic plasticity |
| GO:0051146 | 1.15% | striated muscle cell differentiation |
| GO:0045773 | 1.15% | positive regulation of axon extension |
| GO:0045931 | 1.15% | positive regulation of mitotic cell cycle |
| GO:0046942 | 1.15% | carboxylic acid transport |
| GO:0060485 | 1.15% | mesenchyme development |
| GO:0060348 | 1.15% | bone development |
| GO:0006026 | 1.15% | aminoglycan catabolic process |
| GO:0090407 | 1.15% | organophosphate biosynthetic process |
| GO:0042753 | 1.15% | positive regulation of circadian rhythm |
| GO:0050708 | 1.15% | regulation of protein secretion |
| GO:1903827 | 1.15% | regulation of cellular protein localization |
| GO:0002209 | 1.15% | behavioral defense response |
| GO:0010029 | 1.15% | regulation of seed germination |
| GO:0043330 | 1.14% | response to exogenous dsRNA |
| GO:0032392 | 1.14% | DNA geometric change |
| GO:0006521 | 1.14% | regulation of cellular amino acid metabolic process |
| GO:2001032 | 1.14% | regulation of double-strand break repair via nonhomologous end joining |
| GO:0045806 | 1.14% | negative regulation of endocytosis |
| GO:0071621 | 1.14% | granulocyte chemotaxis |
| GO:0002040 | 1.14% | sprouting angiogenesis |
| GO:0016241 | 1.14% | regulation of macroautophagy |
| GO:0002701 | 1.14% | negative regulation of production of molecular mediator of immune response |
| GO:0006359 | 1.14% | regulation of transcription by RNA polymerase III |
| GO:1904951 | 1.13% | positive regulation of establishment of protein localization |
| GO:0042762 | 1.13% | regulation of sulfur metabolic process |
| GO:1903522 | 1.13% | regulation of blood circulation |
| GO:0000079 | 1.13% | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0032352 | 1.13% | positive regulation of hormone metabolic process |
| GO:0008016 | 1.13% | regulation of heart contraction |
| GO:0006364 | 1.13% | rRNA processing |
| GO:0061005 | 1.13% | cell differentiation involved in kidney development |
| GO:0006298 | 1.13% | mismatch repair |
| GO:0048286 | 1.13% | lung alveolus development |
| GO:0007368 | 1.13% | determination of left/right symmetry |
| GO:0014048 | 1.13% | regulation of glutamate secretion |
| GO:0001782 | 1.13% | B cell homeostasis |
| GO:0021953 | 1.13% | central nervous system neuron differentiation |
| GO:0000105 | 1.13% | histidine biosynthetic process |
| GO:0048806 | 1.13% | genitalia development |
| GO:0007517 | 1.12% | muscle organ development |
| GO:0006887 | 1.12% | exocytosis |
| GO:0007339 | 1.12% | binding of sperm to zona pellucida |
| GO:0001569 | 1.12% | branching involved in blood vessel morphogenesis |
| GO:0044403 | 1.12% | symbiotic process |
| GO:1901798 | 1.12% | positive regulation of signal transduction by p53 class mediator |
| GO:0034470 | 1.12% | ncRNA processing |
| GO:0043632 | 1.12% | modification-dependent macromolecule catabolic process |
| GO:0090150 | 1.12% | establishment of protein localization to membrane |
| GO:0043270 | 1.12% | positive regulation of ion transport |
| GO:0010656 | 1.12% | negative regulation of muscle cell apoptotic process |
| GO:0051353 | 1.12% | positive regulation of oxidoreductase activity |
| GO:0016311 | 1.12% | dephosphorylation |
| GO:0033143 | 1.12% | regulation of intracellular steroid hormone receptor signaling pathway |
| GO:0006910 | 1.12% | phagocytosis, recognition |
| GO:0019941 | 1.12% | modification-dependent protein catabolic process |
| GO:0050868 | 1.12% | negative regulation of T cell activation |
| GO:0045124 | 1.12% | regulation of bone resorption |
| GO:0031648 | 1.12% | protein destabilization |
| GO:0007520 | 1.11% | myoblast fusion |
| GO:0048713 | 1.11% | regulation of oligodendrocyte differentiation |
| GO:0000578 | 1.11% | embryonic axis specification |
| GO:0006366 | 1.11% | transcription by RNA polymerase II |
| GO:1901739 | 1.11% | regulation of myoblast fusion |
| GO:0045739 | 1.11% | positive regulation of DNA repair |
| GO:0042168 | 1.11% | heme metabolic process |
| GO:0031069 | 1.11% | hair follicle morphogenesis |
| GO:0008088 | 1.11% | axo-dendritic transport |
| GO:1902019 | 1.11% | regulation of cilium-dependent cell motility |
| GO:0046631 | 1.11% | alpha-beta T cell activation |
| GO:0002720 | 1.11% | positive regulation of cytokine production involved in immune response |
| GO:0015844 | 1.11% | monoamine transport |
| GO:0033077 | 1.11% | T cell differentiation in thymus |
| GO:0070229 | 1.11% | negative regulation of lymphocyte apoptotic process |
| GO:0044242 | 1.11% | cellular lipid catabolic process |
| GO:1903901 | 1.11% | negative regulation of viral life cycle |
| GO:0007588 | 1.11% | excretion |
| GO:0006778 | 1.11% | porphyrin-containing compound metabolic process |
| GO:0070507 | 1.10% | regulation of microtubule cytoskeleton organization |
| GO:0071398 | 1.10% | cellular response to fatty acid |
| GO:0034293 | 1.10% | sexual sporulation |
| GO:0031056 | 1.10% | regulation of histone modification |
| GO:0002764 | 1.10% | immune response-regulating signaling pathway |
| GO:0090207 | 1.10% | regulation of triglyceride metabolic process |
| GO:0097755 | 1.10% | positive regulation of blood vessel diameter |
| GO:0046888 | 1.10% | negative regulation of hormone secretion |
| GO:0022404 | 1.10% | molting cycle process |
| GO:0071852 | 1.10% | fungal-type cell wall organization or biogenesis |
| GO:0010884 | 1.10% | positive regulation of lipid storage |
| GO:0060456 | 1.10% | positive regulation of digestive system process |
| GO:1901983 | 1.09% | regulation of protein acetylation |
| GO:0000422 | 1.09% | autophagy of mitochondrion |
| GO:1903524 | 1.09% | positive regulation of blood circulation |
| GO:0110053 | 1.09% | regulation of actin filament organization |
| GO:0016055 | 1.09% | Wnt signaling pathway |
| GO:0010447 | 1.09% | response to acidic pH |
| GO:0008277 | 1.09% | regulation of G protein-coupled receptor signaling pathway |
| GO:0043388 | 1.09% | positive regulation of DNA binding |
| GO:0014896 | 1.09% | muscle hypertrophy |
| GO:0001657 | 1.09% | ureteric bud development |
| GO:1902903 | 1.09% | regulation of supramolecular fiber organization |
| GO:0007007 | 1.09% | inner mitochondrial membrane organization |
| GO:0014743 | 1.09% | regulation of muscle hypertrophy |
| GO:0035036 | 1.09% | sperm-egg recognition |
| GO:0043484 | 1.09% | regulation of RNA splicing |
| GO:0001837 | 1.09% | epithelial to mesenchymal transition |
| GO:0015979 | 1.09% | photosynthesis |
| GO:0007159 | 1.08% | leukocyte cell-cell adhesion |
| GO:1903829 | 1.08% | positive regulation of cellular protein localization |
| GO:0006664 | 1.08% | glycolipid metabolic process |
| GO:0010596 | 1.08% | negative regulation of endothelial cell migration |
| GO:0032692 | 1.08% | negative regulation of interleukin-1 production |
| GO:0000226 | 1.08% | microtubule cytoskeleton organization |
| GO:0032890 | 1.08% | regulation of organic acid transport |
| GO:0046850 | 1.08% | regulation of bone remodeling |
| GO:0032691 | 1.08% | negative regulation of interleukin-1 beta production |
| GO:0022409 | 1.08% | positive regulation of cell-cell adhesion |
| GO:0006446 | 1.08% | regulation of translational initiation |
| GO:0072175 | 1.08% | epithelial tube formation |
| GO:0046685 | 1.07% | response to arsenic-containing substance |
| GO:0030031 | 1.07% | cell projection assembly |
| GO:0006119 | 1.07% | oxidative phosphorylation |
| GO:1902275 | 1.07% | regulation of chromatin organization |
| GO:0009624 | 1.07% | response to nematode |
| GO:0042254 | 1.07% | ribosome biogenesis |
| GO:0046337 | 1.07% | phosphatidylethanolamine metabolic process |
| GO:2000756 | 1.07% | regulation of peptidyl-lysine acetylation |
| GO:0044319 | 1.07% | wound healing, spreading of cells |
| GO:0001953 | 1.07% | negative regulation of cell-matrix adhesion |
| GO:0009595 | 1.07% | detection of biotic stimulus |
| GO:0035264 | 1.07% | multicellular organism growth |
| GO:0070849 | 1.07% | response to epidermal growth factor |
| GO:0046825 | 1.07% | regulation of protein export from nucleus |
| GO:0000398 | 1.06% | mRNA splicing, via spliceosome |
| GO:0035813 | 1.06% | regulation of renal sodium excretion |
| GO:0031098 | 1.06% | stress-activated protein kinase signaling cascade |
| GO:0045933 | 1.06% | positive regulation of muscle contraction |
| GO:0032508 | 1.06% | DNA duplex unwinding |
| GO:0098581 | 1.06% | detection of external biotic stimulus |
| GO:0016054 | 1.06% | organic acid catabolic process |
| GO:0006690 | 1.06% | icosanoid metabolic process |
| GO:0048010 | 1.06% | vascular endothelial growth factor receptor signaling pathway |
| GO:0045823 | 1.06% | positive regulation of heart contraction |
| GO:0045069 | 1.06% | regulation of viral genome replication |
| GO:0043407 | 1.06% | negative regulation of MAP kinase activity |
| GO:1903747 | 1.06% | regulation of establishment of protein localization to mitochondrion |
| GO:0009630 | 1.06% | gravitropism |
| GO:1905475 | 1.06% | regulation of protein localization to membrane |
| GO:0030593 | 1.06% | neutrophil chemotaxis |
| GO:0010518 | 1.06% | positive regulation of phospholipase activity |
| GO:0042311 | 1.05% | vasodilation |
| GO:0070252 | 1.05% | actin-mediated cell contraction |
| GO:0099111 | 1.05% | microtubule-based transport |
| GO:0006656 | 1.05% | phosphatidylcholine biosynthetic process |
| GO:0001556 | 1.05% | oocyte maturation |
| GO:0007492 | 1.05% | endoderm development |
| GO:0098926 | 1.05% | postsynaptic signal transduction |
| GO:0000280 | 1.05% | nuclear division |
| GO:0007163 | 1.05% | establishment or maintenance of cell polarity |
| GO:2001057 | 1.05% | reactive nitrogen species metabolic process |
| GO:0009112 | 1.05% | nucleobase metabolic process |
| GO:0010800 | 1.05% | positive regulation of peptidyl-threonine phosphorylation |
| GO:0098657 | 1.05% | import into cell |
| GO:0007297 | 1.04% | ovarian follicle cell migration |
| GO:0060281 | 1.04% | regulation of oocyte development |
| GO:0060968 | 1.04% | regulation of gene silencing |
| GO:0045921 | 1.04% | positive regulation of exocytosis |
| GO:0045055 | 1.04% | regulated exocytosis |
| GO:0045980 | 1.04% | negative regulation of nucleotide metabolic process |
| GO:1903509 | 1.04% | liposaccharide metabolic process |
| GO:0060688 | 1.04% | regulation of morphogenesis of a branching structure |
| GO:0048013 | 1.04% | ephrin receptor signaling pathway |
| GO:1900006 | 1.04% | positive regulation of dendrite development |
| GO:0090596 | 1.04% | sensory organ morphogenesis |
| GO:1902884 | 1.04% | positive regulation of response to oxidative stress |
| GO:0032663 | 1.04% | regulation of interleukin-2 production |
| GO:0030316 | 1.04% | osteoclast differentiation |
| GO:0010828 | 1.04% | positive regulation of glucose transmembrane transport |
| GO:0090049 | 1.04% | regulation of cell migration involved in sprouting angiogenesis |
| GO:0042773 | 1.03% | ATP synthesis coupled electron transport |
| GO:0017001 | 1.03% | antibiotic catabolic process |
| GO:0051457 | 1.03% | maintenance of protein location in nucleus |
| GO:0046395 | 1.03% | carboxylic acid catabolic process |
| GO:0009152 | 1.03% | purine ribonucleotide biosynthetic process |
| GO:0007088 | 1.03% | regulation of mitotic nuclear division |
| GO:0046688 | 1.03% | response to copper ion |
| GO:0050670 | 1.03% | regulation of lymphocyte proliferation |
| GO:0002244 | 1.03% | hematopoietic progenitor cell differentiation |
| GO:1903037 | 1.03% | regulation of leukocyte cell-cell adhesion |
| GO:0006692 | 1.03% | prostanoid metabolic process |
| GO:0002757 | 1.03% | immune response-activating signal transduction |
| GO:0001659 | 1.03% | temperature homeostasis |
| GO:0006305 | 1.03% | DNA alkylation |
| GO:0010574 | 1.03% | regulation of vascular endothelial growth factor production |
| GO:0098930 | 1.03% | axonal transport |
| GO:0090502 | 1.03% | RNA phosphodiester bond hydrolysis, endonucleolytic |
| GO:0034695 | 1.02% | response to prostaglandin E |
| GO:0006325 | 1.02% | chromatin organization |
| GO:0048701 | 1.02% | embryonic cranial skeleton morphogenesis |
| GO:1903051 | 1.02% | negative regulation of proteolysis involved in cellular protein catabolic process |
| GO:0007265 | 1.02% | Ras protein signal transduction |
| GO:0030203 | 1.02% | glycosaminoglycan metabolic process |
| GO:0002181 | 1.02% | cytoplasmic translation |
| GO:0048871 | 1.02% | multicellular organismal homeostasis |
| GO:1900426 | 1.02% | positive regulation of defense response to bacterium |
| GO:0045727 | 1.02% | positive regulation of translation |
| GO:0010718 | 1.02% | positive regulation of epithelial to mesenchymal transition |
| GO:0050851 | 1.02% | antigen receptor-mediated signaling pathway |
| GO:0072507 | 1.02% | divalent inorganic cation homeostasis |
| GO:0006338 | 1.02% | chromatin remodeling |
| GO:0050770 | 1.02% | regulation of axonogenesis |
| GO:0010517 | 1.02% | regulation of phospholipase activity |
| GO:0006875 | 1.02% | cellular metal ion homeostasis |
| GO:0045672 | 1.01% | positive regulation of osteoclast differentiation |
| GO:0033047 | 1.01% | regulation of mitotic sister chromatid segregation |
| GO:0008654 | 1.01% | phospholipid biosynthetic process |
| GO:0002706 | 1.01% | regulation of lymphocyte mediated immunity |
| GO:0032354 | 1.01% | response to follicle-stimulating hormone |
| GO:0000959 | 1.01% | mitochondrial RNA metabolic process |
| GO:1904666 | 1.01% | regulation of ubiquitin protein ligase activity |
| GO:2000772 | 1.01% | regulation of cellular senescence |
| GO:0001990 | 1.01% | regulation of systemic arterial blood pressure by hormone |
| GO:1901970 | 1.01% | positive regulation of mitotic sister chromatid separation |
| GO:0010863 | 1.01% | positive regulation of phospholipase C activity |
| GO:1903038 | 1.01% | negative regulation of leukocyte cell-cell adhesion |
| GO:0050926 | 1.01% | regulation of positive chemotaxis |
| GO:0019318 | 1.01% | hexose metabolic process |
| GO:0009799 | 1.01% | specification of symmetry |
| GO:0031047 | 1.01% | gene silencing by RNA |
| GO:0060143 | 1.01% | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0043302 | 1.01% | positive regulation of leukocyte degranulation |
| GO:2000142 | 1.01% | regulation of DNA-templated transcription, initiation |
| GO:0006122 | 1.01% | mitochondrial electron transport, ubiquinol to cytochrome c |
| GO:0042447 | 1.00% | hormone catabolic process |
| GO:0046390 | 1.00% | ribose phosphate biosynthetic process |
| GO:0032259 | 1.00% | methylation |
| GO:0001975 | 1.00% | response to amphetamine |
| GO:0046189 | 1.00% | phenol-containing compound biosynthetic process |
| GO:0022613 | 1.00% | ribonucleoprotein complex biogenesis |
| GO:0006027 | 1.00% | glycosaminoglycan catabolic process |
| GO:0000712 | 1.00% | resolution of meiotic recombination intermediates |
| GO:1902993 | 1.00% | positive regulation of amyloid precursor protein catabolic process |
| GO:0002822 | 1.00% | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |